Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
A gland in males that surrounds the neck of the URINARY BLADDER and the URETHRA. It secretes a substance that liquefies coagulated semen. It is situated in the pelvic cavity behind the lower part of the PUBIC SYMPHYSIS, above the deep layer of the triangular ligament, and rests upon the RECTUM.
Tumors or cancer of the PROSTATE.
Removal of all or part of the PROSTATE, often using a cystoscope and/or resectoscope passed through the URETHRA.
Pathological processes involving the PROSTATE or its component tissues.
Drugs that inhibit 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE. They are commonly used to reduce the production of DIHYDROTESTOSTERONE.
A plant genus in the family ARECACEAE, order Arecales, subclass Arecidae. The fruit or the extract (Permixon) is used for PROSTATIC HYPERPLASIA.
An orally active 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE inhibitor. It is used as a surgical alternative for treatment of benign PROSTATIC HYPERPLASIA.
Steroidal compounds in which one or more carbon atoms in the steroid ring system have been substituted with nitrogen atoms.
Blocked urine flow through the bladder neck, the narrow internal urethral opening at the base of the URINARY BLADDER. Narrowing or strictures of the URETHRA can be congenital or acquired. It is often observed in males with enlarged PROSTATE glands.
Inability to empty the URINARY BLADDER with voiding (URINATION).
A premalignant change arising in the prostatic epithelium, regarded as the most important and most likely precursor of prostatic adenocarcinoma. The neoplasia takes the form of an intra-acinar or ductal proliferation of secretory cells with unequivocal nuclear anaplasia, which corresponds to nuclear grade 2 and 3 invasive prostate cancer.
Symptoms of disorders of the lower urinary tract including frequency, NOCTURIA; urgency, incomplete voiding, and URINARY INCONTINENCE. They are often associated with OVERACTIVE BLADDER; URINARY INCOMPETENCE; and INTERSTITIAL CYSTITIS. Lower urinary tract symptoms in males were traditionally called PROSTATISM.
Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS.
A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
Infiltration of inflammatory cells into the parenchyma of PROSTATE. The subtypes are classified by their varied laboratory analysis, clinical presentation and response to treatment.
Abnormalities in the process of URINE voiding, including bladder control, frequency of URINATION, as well as the volume and composition of URINE.
A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer.
The mechanical laws of fluid dynamics as they apply to urine transport.
Lower urinary tract symptom, such as slow urinary stream, associated with PROSTATIC HYPERPLASIA in older men.
Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.
A potent androgenic metabolite of TESTOSTERONE. It is produced by the action of the enzyme 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE.
An oxidoreductase that catalyzes the conversion of 3-oxo-delta4 steroids into their corresponding 5alpha form. It plays an important role in the conversion of TESTOSTERONE into DIHYDROTESTOSTERONE and PROGESTERONE into DIHYDROPROGESTERONE.
A surgical specialty concerned with the study, diagnosis, and treatment of diseases of the urinary tract in both sexes, and the genital tract in the male. Common urological problems include urinary obstruction, URINARY INCONTINENCE, infections, and UROGENITAL NEOPLASMS.
Benign proliferation of the ENDOMETRIUM in the UTERUS. Endometrial hyperplasia is classified by its cytology and glandular tissue. There are simple, complex (adenomatous without atypia), and atypical hyperplasia representing also the ascending risk of becoming malignant.
Complete or partial surgical removal of the prostate. Three primary approaches are commonly employed: suprapubic - removal through an incision above the pubis and through the urinary bladder; retropubic - as for suprapubic but without entering the urinary bladder; and transurethral (TRANSURETHRAL RESECTION OF PROSTATE).
Discharge of URINE, liquid waste processed by the KIDNEY, from the body.
The use of photothermal effects of LASERS to coagulate, incise, vaporize, resect, dissect, or resurface tissue.
Pathological processes of the URINARY TRACT in both males and females.
The unspecified form of the steroid, normally a major metabolite of TESTOSTERONE with androgenic activity. It has been implicated as a regulator of gonadotropin secretion.
An orally active synthetic progestational hormone used often in combinations as an oral contraceptive.
Proteins, generally found in the CYTOPLASM, that specifically bind ANDROGENS and mediate their cellular actions. The complex of the androgen and receptor migrates to the CELL NUCLEUS where it induces transcription of specific segments of DNA.
A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL.
Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power.
A plant genus of the family ROSACEAE. Bark extract of P. africanum is an ingredient of folk remedies to treat PROSTATIC HYPERPLASIA.
Surgery performed on the male genitalia.
A group of inherited disorders of the ADRENAL GLANDS, caused by enzyme defects in the synthesis of cortisol (HYDROCORTISONE) and/or ALDOSTERONE leading to accumulation of precursors for ANDROGENS. Depending on the hormone imbalance, congenital adrenal hyperplasia can be classified as salt-wasting, hypertensive, virilizing, or feminizing. Defects in STEROID 21-HYDROXYLASE; STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE; 3-beta-hydroxysteroid dehydrogenase (3-HYDROXYSTEROID DEHYDROGENASES); TESTOSTERONE 5-ALPHA-REDUCTASE; or steroidogenic acute regulatory protein; among others, underlie these disorders.
Unsaturated androstane derivatives which are substituted with two hydroxy groups in any position in the ring system.
An increase in the volume of money and credit relative to available goods resulting in a substantial and continuing rise in the general price level.
A synthetic steroid with progestational activity.
An ester of TESTOSTERONE with a propionate substitution at the 17-beta position.
All the organs involved in reproduction and the formation and release of URINE. It includes the kidneys, ureters, BLADDER; URETHRA, and the organs of reproduction - ovaries, UTERUS; FALLOPIAN TUBES; VAGINA; and CLITORIS in women and the testes; SEMINAL VESICLES; PROSTATE; seminal ducts; and PENIS in men.
The measurement of an organ in volume, mass, or heaviness.
The inability in the male to have a PENILE ERECTION due to psychological or organ dysfunction.
Surgical removal or artificial destruction of gonads.
A plant genus of the family SMILACACEAE. Members contain smiglasides (phenylpropanoid glycosides) and steroidal saponins. Commercially it is sometimes adulterated with HEMIDESMUS, which would affect experimental results.
An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.2.
Thioglucosides are organic compounds primarily found in plants, characterized by the functional group consisting of a sulfur atom linked to a glucose molecule through a sulfur-carbon bond.
A malignant epithelial tumor with a glandular organization.
A plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida.
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
Partial or complete blockage in any part of the URETHRA that can lead to difficulty or inability to empty the URINARY BLADDER. It is characterized by an enlarged, often damaged, bladder with frequent urges to void.
Division of tissues by a high-frequency current applied locally with a metal instrument or needle. (Stedman, 25th ed)
Passage of a CATHETER into the URINARY BLADDER or kidney.
Use of plants or herbs to treat diseases or to alleviate pain.
Glycoprotein found in alpha(1)-globulin region in human serum. It inhibits chymotrypsin-like proteinases in vivo and has cytotoxic killer-cell activity in vitro. The protein also has a role as an acute-phase protein and is active in the control of immunologic and inflammatory processes, and as a tumor marker. It is a member of the serpin superfamily.
Non-inflammatory enlargement of the gingivae produced by factors other than local irritation. It is characteristically due to an increase in the number of cells. (From Jablonski's Dictionary of Dentistry, 1992, p400)
Frequent URINATION at night that interrupts sleep. It is often associated with outflow obstruction, DIABETES MELLITUS, or bladder inflammation (CYSTITIS).
Enlargement of the thymus. A condition described in the late 1940's and 1950's as pathological thymic hypertrophy was status thymolymphaticus and was treated with radiotherapy. Unnecessary removal of the thymus was also practiced. It later became apparent that the thymus undergoes normal physiological hypertrophy, reaching a maximum at puberty and involuting thereafter. The concept of status thymolymphaticus has been abandoned. Thymus hyperplasia is present in two thirds of all patients with myasthenia gravis. (From Segen, Dictionary of Modern Medicine, 1992; Cecil Textbook of Medicine, 19th ed, p1486)
Connective tissue cells of an organ found in the loose connective tissue. These are most often associated with the uterine mucosa and the ovary as well as the hematopoietic system and elsewhere.
Methods and procedures for the diagnosis of diseases or dysfunction of the urinary tract or its organs or demonstration of its physiological processes.
Solitary or multiple benign hepatic vascular tumors, usually occurring in women of 20-50 years of age. The nodule, poorly encapsulated, consists of a central stellate fibrous scar and normal liver elements such as HEPATOCYTES, small BILE DUCTS, and KUPFFER CELLS among the intervening fibrous septa. The pale colored central scar represents large blood vessels with hyperplastic fibromuscular layer and narrowing lumen.
The surgical removal of one or both testicles.
Compounds which inhibit or antagonize the biosynthesis or actions of androgens.
Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard.
A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
The duct which coveys URINE from the pelvis of the KIDNEY through the URETERS, BLADDER, and URETHRA.
A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the bladder via the ureters (URETER), and is held there until URINATION.
A subclass of alpha-adrenergic receptors that mediate contraction of SMOOTH MUSCLE in a variety of tissues such as ARTERIOLES; VEINS; and the UTERUS. They are usually found on postsynaptic membranes and signal through GQ-G11 G-PROTEINS.
A plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida. Bixa contains bixin. Cochlospermum contains arjunolic acid and gum kondagogu (POLYSACCHARIDES).
Drugs used in the treatment of urogenital conditions and diseases such as URINARY INCONTINENCE; PROSTATIC HYPERPLASIA; and ERECTILE DYSFUNCTION.
A tube that transports URINE from the URINARY BLADDER to the outside of the body in both the sexes. It also has a reproductive function in the male by providing a passage for SPERM.
Proteins secreted by the prostate gland. The major secretory proteins from the human prostate gland include PROSTATE-SPECIFIC ANTIGEN, prostate-specific acid phosphatase, prostate-specific membrane antigen, and prostate-specific protein-94.
A group of compounds that contain the structure SO2NH2.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
A subtype of thioredoxin reductase found primarily in MITOCHONDRIA.
An enzyme that catalyzes the reduction of TESTOSTERONE to 5-ALPHA DIHYDROTESTOSTERONE.
One or more layers of EPITHELIAL CELLS, supported by the basal lamina, which covers the inner or outer surfaces of the body.
Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional epithelial cells.
Compounds that specifically inhibit PHOSPHODIESTERASE 5.
The innermost layer of an artery or vein, made up of one layer of endothelial cells and supported by an internal elastic lamina.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or body fluids. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including hormones, antigens, amino and nucleic acids, enzymes, polyamines, and specific cell membrane proteins and lipids.
The emission of SEMEN to the exterior, resulting from the contraction of muscles surrounding the male internal urogenital ducts.
Diseases of the domestic dog (Canis familiaris). This term does not include diseases of wild dogs, WOLVES; FOXES; and other Canidae for which the heading CARNIVORA is used.
A family of trypsin-like SERINE ENDOPEPTIDASES that are expressed in a variety of cell types including human prostate epithelial cells. They are formed from tissue prokallikrein by action with TRYPSIN. They are highly similar to PROSTATE-SPECIFIC ANTIGEN.
A group of pyrido-indole compounds. Included are any points of fusion of pyridine with the five-membered ring of indole and any derivatives of these compounds. These are similar to CARBAZOLES which are benzo-indoles.
The emission of SEMEN and seminal fluid during the act of preparation for sexual intercourse, i.e. before there is penetration, or shortly after penetration.
Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens.
Symptom of overactive detrusor muscle of the URINARY BLADDER that contracts with abnormally high frequency and urgency. Overactive bladder is characterized by the frequent feeling of needing to urinate during the day, during the night, or both. URINARY INCONTINENCE may or may not be present.
Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.
All of the processes involved in increasing CELL NUMBER including CELL DIVISION.
The use of focused, high-frequency sound waves to produce local hyperthermia in certain diseased or injured parts of the body or to destroy the diseased tissue.
The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION.

Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers. (1/1254)

Whether oncogenic human papilloma viruses (HPVs) are involved in the pathogenesis of prostate cancers has been a subject of great controversy. To clarify the contradictory results of investigations, with the aim of detecting viral nucleic acids in prostate cancers, we have carried out a comparative quantitation of the HPV16-E6 sequence in 84 prostate specimens. Using single-tube quantitative competitive PCR, we characterized 47 prostate cancers and 37 control tissues of benign prostatic hyperplasia. A subgroup of the prostate tumors (10 of 47; 21%) was detected as having significantly higher copy numbers of HPV16-E6 sequences when compared to the control tissue (1 of 37; 3%), using a cutoff value of 300 copies per 12,500 diploid cells (two-sided Fisher's exact test, P = 0.02). Our results indicate that the oncogenic HPV16 might contribute to the development of a subset of prostate tumors.  (+info)

Utility of ultrasound of the upper urinary tract in elderly men with indicators of obstructive symptoms or abnormal flow: how often can silent hydronephrosis be detected in general practice? (2/1254)

BACKGROUND AND OBJECTIVE: While the prevalence of hydronephrosis is very low in obduction studies, a prevalence of 3-13% is reported for patients with an obstruction who are listed for prostatectomy. In order to evaluate the usefulness of transabdominal ultrasound in primary care, we determined the occurrence of hydronephrosis in males with symptoms of urinary obstruction in a general practice setting. METHOD: A micturition questionnaire (a modified Boyarsky) was sent to all men of 55 years or more who were registered in 10 general practices in Maastricht, and was followed by an examination at their general practice. Men with obstructive symptoms and/or with a free-flow abnormality were examined in the hospital with transabdominal ultrasound in order to detect dilatation of the upper urinary tract. This ultrasound was repeated approximately 15 months later. RESULTS: At the first measurement, none of the examined men (n = 178) had hydronephrosis, and this was still the case for 94 men 15 months later. CONCLUSION: Renal ultrasound is not necessary in general practice for men with uncomplicated obstructive complaints.  (+info)

Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesions. (3/1254)

In situ hybridization and immunohistochemistry were used to localize and compare the expression of the long form of the human prolactin receptor in fetal, prepubertal, and adult prostate. Results were then compared with hyperplastic, dysplastic, and neoplastic lesions. Both receptor message and protein were predominately localized in epithelial cells of the fetal, neonatal, prepubertal, and normal adult prostate. In hyperplastic lesions the expression of the receptor was unchanged with respect to normal epithelial cells. Irrespective of grade, markedly enhanced expression of the receptor was evident in dysplastic lesions. In lower Gleason grade carcinomas the intensity of receptor signal at the message and protein levels approximated that found in normal prostatic epithelium. However, in foci within higher grade cancers, receptor expression appeared diminished. Results from our study suggest that prolactin action plays a role in the development and maintenance of the human prostate and may also participate in early neoplastic transformation of the gland. Diminution of receptor expression in high grade neoplasms could reflect the emergence of a population of cells that are no longer responsive to the peptide hormone.  (+info)

Prostatic intraepithelial neoplasia and apoptosis in benign prostatic hyperplasia before and after the Chernobyl accident in Ukraine. (4/1254)

The prevalence of prostatic intraepithelial neoplasia (PIN) in men who underwent surgery for benign prostatic hyperplasia (BPH) before and after the Chernobyl nuclear accident was studied. BPH samples were obtained by adenomectomy from 45 patients operated in 1984 before the accident (Group I), and 47 patients from the low contaminated Kiev City (Group II) and 76 from high contaminated area (Group III) operated between 1996 and 1998. Their BPH samples were examined histologically and immunohistochemically. The incidences of prostatic intraepithelial neoplasia (PIN) and high grade PIN (HGPIN) were 15.5 and 11.1% in Group I, 29.8 and 14.9% in Grpoup II, and 35. 5 and 19.7% in Group III. The difference between the incidences of PIN in Group I and III is significant (p<0.02). There was increased apoptosis in areas of PIN in Group II and III as compared to Group I (p<0.001). Since apoptosis has been shown to be associated with ionizing radiation and it is now found to be associated with PIN in patients diagnosed after the Chernobyl nuclear accident, this suggests that long-term low dose internal ionizing radiation potentially may cause prostate cancer.  (+info)

The spontaneously hypertensive rat: insight into the pathogenesis of irritative symptoms in benign prostatic hyperplasia and young anxious males. (5/1254)

Recent epidemiological studies have shown that hypertensive men are more likely to undergo surgical intervention for irritative voiding symptoms from BPH than age-matched controls. Indeed, noradrenergic nerves which regulate vascular tone also participate in the functional component of bladder outlet obstruction due to BPH. Newer, less invasive therapies for BPH such as thermal therapy can relieve symptoms yet do not eliminate obstruction based on urodynamic studies. Coincidentally, drugs such as alpha-adrenoceptor antagonists, which have been thought to relieve obstruction due to a peripheral effect, can be given intrathecally in animals to relieve urinary frequency due to obstruction. Taken together these observations implicate both peripheral and central sympathetic pathways in the motor control of the urinary bladder especially with disease states. We have used the hypertensive and behaviourally hyperactive spontaneously hypertensive rat (SHR), to investigate the roles sympathetic pathways or micturition. Elevated nerve growth factor (NGF) derived from vascular and bladder smooth muscle cells of the SHR appears to direct morphological, biochemical, and functional changes. The increase in NGF can apparently be explained by stabilization of its mRNA leading to increased synthesis in NGF. Bladders from SHRs develop a profuse noradrenergic hyperinnervation compared with the control WKY strain. Since afferents supplying the SHR bladder are hypertrophied, changes in afferent pathways are also likely. These differences in innervation and NGF in the SHR may explain changes in function. SHRs void 3 times as frequently as their genetic controls. Urinary frequency can be reduced by alpha-adrenoceptor antagonists. Cystometrograms performed in SHRs reveal lower bladder capacities and micturition volumes and the presence of unstable contractions compared with the WKY rat. Intrathecal, rather than intra-arterial administration of the alpha-adrenoceptor antagonist doxazosin reduces unstable contractions in the SHR. In vitro muscle bath studies have shown enhanced responses of SHR bladder smooth muscle to alpha-adrenoceptor agonists. It is likely that upregulation of NGF production causes sensory and possibly noradrenergic pathways to elicit hyperactive voiding. Increase in NGF in the adult bladder due to pathological conditions yields similar, yet distinct, consequences for voiding behaviour and innervation. Likewise, increased NGF in adult bladders following obstruction or inflammation triggers neuronal hypertrophy, enhanced reflex activity and urinary frequency. In contrast to the SHR, hyper-innervation is not observed. Moreover, peripheral or spinal alpha-adrenoceptor blockade eliminates urinary frequency following obstruction. These observations support the role for sympathetic pathways in the motor function of the bladder, especially in congenital or adult disease states. A similar process may underlie the neuroplasticity involved in alterations after obstruction or inflammation of the lower urinary tract in humans. The SHR strain raises the possibility that a common genetic defect exists capable of predisposing to both hypertension and overactivity of the urinary bladder. Whether a genetic predisposition to sustained bladder overactivity in response to inflammatory stimuli in obstruction exists in humans is an intriguing prospect.  (+info)

Malignant transformation of human prostatic epithelium is associated with the loss of androgen receptor immunoreactivity in the surrounding stroma. (6/1254)

The cellular pathways involved in the pathogenesis of hormone resistance remain unclear. Studies evaluating the role of changes in human androgen receptor (hAR) expression in the progression of prostatic tumors have been inconclusive. Androgenic influence over prostatic growth is mediated via the regulation of interactions between stromal and epithelial cells. We hypothesized that neoplastic transformation of the prostate would be associated with alterations in hAR expression in the adjacent stroma. Using immunohistochemical techniques, we determined hAR positivity in the epithelium and adjacent stroma of sections from 17 benign and 39 malignant prostatic glands. We found that whereas the expression of the receptor decreased in both cellular compartments as the tissues dedifferentiated, the depletion was more pronounced in the stromal nuclei (P<0.0001). However, in sections from both untreated and hormone-resistant prostate cancer tissues, although heterogeneity of hAR expression in malignant epithelia was increased, there appeared to be a unique field effect around the cancerous prostate glands that resulted in a decreased expression of the receptor in the adjacent benign glands and its total loss in the surrounding stroma. The loss of hAR in the stroma adjacent to malignant prostatic epithelium may play an important role in prostate cancer progression. Furthermore, the similarity of the lack of stromal hAR expression in newly diagnosed and hormone-resistant prostate cancer (P = 0.85) may be an indication that the mechanisms responsible for the acquisition of hormone independence are established early in the malignant transformation process.  (+info)

Comparison of NHS and private patients undergoing elective transurethral resection of the prostate for benign prostatic hypertrophy. (7/1254)

OBJECTIVES: To compare the operative thresholds and clinical management of men undergoing elective transurethral resection of the prostate for benign prostatic hypertrophy in the NHS and privately. DESIGN: Cohort study of patients recruited by 25 surgeons during 1988. SETTING: Hospitals in Oxford and North West Thames regions. PATIENTS: Of 400 consecutive patients, 129 were excluded because of open surgery (nine), lack of surgeons' information (three), and emergency admission (117) and three failed to give information, leaving 268 patients, 214 NHS patients and 54 private patients. MAIN MEASURES: Sociodemographic factors, prevalence and severity of symptoms, comorbidity, general health (Nottingham health profile) obtained from patient questionnaire preoperatively and reasons for operating, and operative management obtained from surgeons perioperatively. RESULTS: NHS and private patients were similar in severity of symptoms and prevalence of urinary tract abnormalities. They differed in four respects: NHS patients' general health was poorer as a consequence of more comorbid conditions (49, 23% v 7, 13% in severe category); the condition had a greater detrimental effect on their lives (36, 17% v 2, 4% severely affected; p < 0.01); private patients received more personalised care more quickly and were investigated more before surgery, (29, 54% v 60, 20% receiving ultrasonography of the urinary tract); and NHS patients stayed in hospital longer (57, 27% v 3, 6% more than seven days; p < 0.001). CONCLUSIONS: Private patients' need for surgery, judged by symptom severity, was as great as that of NHS patients, and there was no evidence of different operative thresholds in the two sectors, but, judged by impact on lifestyle, NHS patients' need was greater.  (+info)

Roles for Nkx3.1 in prostate development and cancer. (8/1254)

In aging men, the prostate gland becomes hyperproliferative and displays a propensity toward carcinoma. Although this hyperproliferative process has been proposed to represent an inappropriate reactivation of an embryonic differentiation program, the regulatory genes responsible for normal prostate development and function are largely undefined. Here we show that the murine Nkx3.1 homeobox gene is the earliest known marker of prostate epithelium during embryogenesis and is subsequently expressed at all stages of prostate differentiation in vivo as well as in tissue recombinants. A null mutation for Nkx3.1 obtained by targeted gene disruption results in defects in prostate ductal morphogenesis and secretory protein production. Notably, Nkx3.1 mutant mice display prostatic epithelial hyperplasia and dysplasia that increases in severity with age. This epithelial hyperplasia and dysplasia also occurs in heterozygous mice, indicating haploinsufficiency for this phenotype. Because human NKX3.1 is known to map to a prostate cancer hot spot, we propose that NKX3.1 is a prostate-specific tumor suppressor gene and that loss of a single allele may predispose to prostate carcinogenesis. The Nkx3.1 mutant mice provide a unique animal model for examining the relationship between normal prostate differentiation and early stages of prostate carcinogenesis.  (+info)

Prostatic hyperplasia, also known as benign prostatic hyperplasia (BPH), is a noncancerous enlargement of the prostate gland. The prostate gland surrounds the urethra, the tube that carries urine and semen out of the body. When the prostate gland enlarges, it can squeeze or partially block the urethra, causing problems with urination, such as a weak stream, difficulty starting or stopping the flow, and more frequent urination, especially at night. Prostatic hyperplasia is a common condition as men age and does not necessarily lead to cancer. However, it can cause significant discomfort and decreased quality of life if left untreated. Treatment options include medications, minimally invasive procedures, and surgery.

Hyperplasia is a medical term that refers to an abnormal increase in the number of cells in an organ or tissue, leading to an enlargement of the affected area. It's a response to various stimuli such as hormones, chronic irritation, or inflammation. Hyperplasia can be physiological, like the growth of breast tissue during pregnancy, or pathological, like in the case of benign or malignant tumors. The process is generally reversible if the stimulus is removed. It's important to note that hyperplasia itself is not cancerous, but some forms of hyperplasia can increase the risk of developing cancer over time.

The prostate is a small gland that is part of the male reproductive system. Its main function is to produce a fluid that, together with sperm cells from the testicles and fluids from other glands, makes up semen. This fluid nourishes and protects the sperm, helping it to survive and facilitating its movement.

The prostate is located below the bladder and in front of the rectum. It surrounds part of the urethra, the tube that carries urine and semen out of the body. This means that prostate problems can affect urination and sexual function. The prostate gland is about the size of a walnut in adult men.

Prostate health is an important aspect of male health, particularly as men age. Common prostate issues include benign prostatic hyperplasia (BPH), which is an enlarged prostate not caused by cancer, and prostate cancer, which is one of the most common types of cancer in men. Regular check-ups with a healthcare provider can help to detect any potential problems early and improve outcomes.

Prostatic neoplasms refer to abnormal growths in the prostate gland, which can be benign or malignant. The term "neoplasm" simply means new or abnormal tissue growth. When it comes to the prostate, neoplasms are often referred to as tumors.

Benign prostatic neoplasms, such as prostate adenomas, are non-cancerous overgrowths of prostate tissue. They usually grow slowly and do not spread to other parts of the body. While they can cause uncomfortable symptoms like difficulty urinating, they are generally not life-threatening.

Malignant prostatic neoplasms, on the other hand, are cancerous growths. The most common type of prostate cancer is adenocarcinoma, which arises from the glandular cells in the prostate. Prostate cancer often grows slowly and may not cause any symptoms for many years. However, some types of prostate cancer can be aggressive and spread quickly to other parts of the body, such as the bones or lymph nodes.

It's important to note that while prostate neoplasms can be concerning, early detection and treatment can significantly improve outcomes for many men. Regular check-ups with a healthcare provider are key to monitoring prostate health and catching any potential issues early on.

Transurethral Resection of Prostate (TURP) is a surgical procedure that involves the removal of the inner part of an enlarged prostate gland using a resectoscope, a tool with a tiny loop of wire at its end that is inserted into the urethra through the penis. The loop of wire is used to cut and remove the excess tissue, which is then washed out of the body. This procedure is typically performed to relieve moderate to severe urinary symptoms caused by an enlarged prostate, such as difficulty in beginning the flow of urine, a weak stream, and frequent urination, especially at night. It is one of the most common surgical procedures for treating benign prostatic hyperplasia (BPH).

Prostatic diseases refer to a range of medical conditions that affect the prostate gland, a small gland that is part of the male reproductive system. The prostate is located below the bladder and surrounds the urethra, the tube that carries urine and semen out of the body. Some common prostatic diseases include:

1. Benign Prostatic Hyperplasia (BPH): This is a non-cancerous enlargement of the prostate gland that can cause difficulties with urination, such as a weak stream, frequent urination, and a feeling of incomplete bladder emptying.
2. Prostatitis: This is an inflammation or infection of the prostate gland that can cause pain, fever, difficulty urinating, and sexual dysfunction.
3. Prostate Cancer: This is a malignant tumor that develops in the prostate gland and can spread to other parts of the body. It is one of the most common types of cancer in men and can often be treated successfully if detected early.
4. Acute Bacterial Prostatitis: This is a sudden and severe infection of the prostate gland that can cause fever, chills, pain in the lower back and genital area, and difficulty urinating.
5. Chronic Bacterial Prostatitis: This is a recurring or persistent bacterial infection of the prostate gland that can cause symptoms similar to chronic pelvic pain syndrome.
6. Chronic Pelvic Pain Syndrome (CPPS): Also known as chronic nonbacterial prostatitis, this condition is characterized by ongoing pain in the pelvic area, often accompanied by urinary and sexual dysfunction. The exact cause of CPPS is not well understood, but it is thought to be related to inflammation or nerve damage in the prostate gland.

5-alpha Reductase Inhibitors are a class of drugs that block the action of the enzyme 5-alpha reductase, which is responsible for converting testosterone to dihydrotestosterone (DHT). DHT is a more potent form of testosterone that plays a key role in the development and maintenance of male sexual characteristics and is involved in the pathogenesis of benign prostatic hyperplasia (BPH) and androgenetic alopecia (male pattern baldness).

By inhibiting the action of 5-alpha reductase, these drugs reduce the levels of DHT in the body, which can help to shrink the prostate gland and improve symptoms of BPH such as difficulty urinating, frequent urination, and weak urine stream. They are also used off-label to treat hair loss in men.

Examples of 5-alpha reductase inhibitors include finasteride (Proscar, Propecia) and dutasteride (Avodart). Common side effects of these drugs may include decreased libido, erectile dysfunction, and breast tenderness or enlargement.

"Serenoa" is the medical term for a type of palm tree, also known as Saw Palmetto. The fruit of this plant, Serenoa repens, is commonly used in herbal medicine, particularly for treating symptoms associated with an enlarged prostate gland, such as reducing difficulty in urinating. It contains compounds that are thought to have anti-inflammatory and hormonal effects. However, it's important to note that the effectiveness of Serenoa repbs for treating medical conditions is still a subject of ongoing research and debate.

Finasteride is a synthetic 4-azasteroid compound that acts as a specific inhibitor of Type II 5α-reductase, an intracellular enzyme that converts testosterone to dihydrotestosterone (DHT). DHT is a hormonal byproduct thought to be responsible for the development and worsening of benign prostatic hyperplasia (BPH) and androgenetic alopecia (AGA), also known as male pattern baldness.

Finasteride is available in two formulations: finasteride 1 mg (Proscar) and finasteride 5 mg (Propecia). Finasteride 1 mg is used to treat BPH, while finasteride 5 mg is used for the treatment of AGA in men. The drug works by reducing the production of DHT, which in turn slows down the progression of BPH and AGA.

It's important to note that finasteride is not approved for use in women or children, and it should be used with caution in men due to potential side effects such as decreased sexual desire, difficulty in achieving an erection, and a decrease in the amount of semen produced.

I'm sorry for any confusion, but "Azasteroids" is not a medical term or concept. The term "azasteroids" is used in the field of chemistry to refer to a class of compounds that are structurally similar to steroids but have an aziridine ring (a three-membered ring containing two carbon atoms and one nitrogen atom) instead of the usual four-membered ring in the steroid structure.

These compounds may have potential applications in various fields, including medicinal chemistry, but they are not a medical concept or diagnosis. If you have any questions related to medical terminology or health concerns, I would be happy to help you with those!

Urinary bladder neck obstruction is a medical condition that refers to a partial or complete blockage at the bladder neck, which is the area where the bladder connects to the urethra. This obstruction can be caused by various factors such as prostate enlargement, bladder tumors, scar tissue, or nerve damage.

The bladder neck obstruction can lead to difficulty in urinating, a weak urine stream, and the need to strain while urinating. In severe cases, it can cause urinary retention, kidney failure, and other complications. Treatment for this condition depends on the underlying cause and may include medications, surgery, or minimally invasive procedures.

Urinary retention is a medical condition in which the bladder cannot empty completely or at all, resulting in the accumulation of urine in the bladder. This can lead to discomfort, pain, and difficulty in passing urine. Urinary retention can be acute (sudden onset) or chronic (long-term). Acute urinary retention is a medical emergency that requires immediate attention, while chronic urinary retention may be managed with medications or surgery. The causes of urinary retention include nerve damage, bladder muscle weakness, prostate gland enlargement, and side effects of certain medications.

Prostatic Intraepithelial Neoplasia (PIN) is a term used in pathology to describe the abnormal growth of cells within the lining of the prostate gland's ducts and acini (small sacs that produce and store fluids). PIN is not considered a cancer, but it can be a precursor to prostate cancer.

There are two types of PIN: low-grade and high-grade. Low-grade PIN shows mild to moderate atypia (abnormalities in the cells), while high-grade PIN displays more significant atypia, which resembles prostate cancer. High-grade PIN is often found close to or within areas of prostate cancer, making it a potential indicator of malignancy.

However, not all cases of high-grade PIN progress to cancer, and some men with high-grade PIN may never develop prostate cancer. Nonetheless, the presence of high-grade PIN might prompt further investigation or monitoring to ensure early detection and treatment of any potential cancer development.

Lower urinary tract symptoms (LUTS) refer to a group of clinical symptoms related to the lower urinary tract, including the bladder and urethra. These symptoms can be categorized into storage, voiding, and post-micturition symptoms. Storage symptoms include frequency, urgency, nocturia, and urinary incontinence. Voiding symptoms consist of hesitancy, slow stream, straining, and intermittent flow. Post-micturition symptoms include a feeling of incomplete bladder emptying and post-void dribbling. LUTS can be caused by various underlying conditions such as benign prostatic hyperplasia (BPH), overactive bladder (OAB), urinary tract infection, neurogenic bladder dysfunction, or bladder cancer. The evaluation and management of LUTS require a comprehensive assessment of the patient's medical history, physical examination, and appropriate diagnostic tests to determine the underlying cause and develop an effective treatment plan.

Adrenergic alpha-1 receptor antagonists, also known as alpha-blockers, are a class of medications that block the effects of the neurotransmitter norepinephrine at alpha-1 receptors. These receptors are found in various tissues throughout the body, including the smooth muscle of blood vessels, the bladder, and the eye.

When norepinephrine binds to alpha-1 receptors, it causes smooth muscle to contract, leading to vasoconstriction (constriction of blood vessels), increased blood pressure, and other effects. By blocking these receptors, alpha-blockers can cause relaxation of smooth muscle, leading to vasodilation (expansion of blood vessels), decreased blood pressure, and other effects.

Alpha-blockers are used in the treatment of various medical conditions, including hypertension (high blood pressure), benign prostatic hyperplasia (enlarged prostate), and pheochromocytoma (a rare tumor of the adrenal gland). Examples of alpha-blockers include doxazosin, prazosin, and terazosin.

It's important to note that while alpha-blockers can be effective in treating certain medical conditions, they can also have side effects, such as dizziness, lightheadedness, and orthostatic hypotension (a sudden drop in blood pressure when standing up). As with any medication, it's important to use alpha-blockers under the guidance of a healthcare provider.

Doxazosin is an antihypertensive drug, which belongs to the class of medications called alpha-1 receptor blockers. It works by relaxing the muscles in the blood vessels, which helps to lower blood pressure and improve blood flow. Doxazosin is primarily used to treat high blood pressure (hypertension) and benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate gland that can cause urinary symptoms such as difficulty in beginning the flow of urine, weak stream, and frequent urination.

The medical definition of Doxazosin is:

Doxazosin mesylate - A selective alpha-1 adrenergic receptor blocker used in the treatment of hypertension and benign prostatic hyperplasia (BPH). It works by relaxing the smooth muscle in blood vessels, which lowers blood pressure and improves blood flow. Doxazosin may also be used off-label for other indications such as Raynaud's phenomenon or painful bladder syndrome. The drug is available in oral tablet form and is typically taken once daily. Common side effects include dizziness, lightheadedness, and headache.

Prostatitis is a medical condition that refers to inflammation of the prostate gland, which can be caused by bacterial or non-bacterial factors. It can present with various symptoms such as pain in the lower abdomen, pelvis, or genital area, difficulty and/or painful urination, ejaculation pain, and flu-like symptoms. Prostatitis can be acute or chronic, and it is important to seek medical attention for proper diagnosis and treatment.

Urination disorders, also known as lower urinary tract symptoms (LUTS), refer to a range of clinical conditions that affect the bladder and urethra, resulting in abnormalities in the storage, transportation, and evacuation of urine. These disorders can be categorized into voiding symptoms, such as hesitancy, straining, slow stream, intermittency, and terminal dribble; and storage symptoms, including frequency, urgency, nocturia, and urge incontinence.

The causes of urination disorders are diverse, encompassing congenital abnormalities, neurological conditions, infections, inflammation, medications, and age-related changes. Common underlying pathologies include bladder overactivity, detrusor muscle instability, underactive bladder, and obstruction of the urethra.

Urination disorders can significantly impact an individual's quality of life, causing physical discomfort, sleep disturbances, emotional distress, and social isolation. Accurate diagnosis and appropriate management require a comprehensive assessment of the patient's medical history, physical examination, urinalysis, and urodynamic studies. Treatment options may include behavioral modifications, pelvic floor exercises, bladder training, medications, neuromodulation, and surgical interventions.

Prostate-Specific Antigen (PSA) is a glycoprotein enzyme produced by the epithelial cells of the prostate gland. It is primarily involved in liquefying semen after ejaculation, allowing sperm mobility.

In clinical medicine, PSA is used as a tumor marker, mainly for monitoring the treatment and recurrence of prostate cancer. Elevated levels of PSA can indicate inflammation, infection, benign prostatic hyperplasia (BPH), or prostate cancer. However, it's important to note that an elevated PSA level does not necessarily confirm cancer; further diagnostic tests like digital rectal examination, transrectal ultrasound, and prostate biopsy are often required for definitive diagnosis.

Doctors may also use PSA isoforms or derivatives, such as free PSA, total PSA, and PSA density, to help improve the specificity of cancer detection and differentiate between malignant and benign conditions.

Urodynamics is a medical test that measures the function and performance of the lower urinary tract, which includes the bladder, urethra, and sphincters. It involves the use of specialized equipment to record measurements such as bladder pressure, urine flow rate, and residual urine volume. The test can help diagnose various urinary problems, including incontinence, urinary retention, and overactive bladder.

During the test, a small catheter is inserted into the bladder through the urethra to measure bladder pressure while filling it with sterile water or saline solution. Another catheter may be placed in the rectum to record abdominal pressure. The patient is then asked to urinate, and the flow rate and any leaks are recorded.

Urodynamics can help identify the underlying cause of urinary symptoms and guide treatment decisions. It is often recommended for patients with complex or persistent urinary problems that have not responded to initial treatments.

"Prostatism" is not a formal medical term, but it is often used informally to refer to lower urinary tract symptoms (LUTS) that are related to bladder outflow obstruction due to benign prostatic hyperplasia (BPH), which is a non-cancerous enlargement of the prostate gland in older men.

The symptoms of prostatism may include:

* Frequency: The need to urinate more often than usual, especially at night.
* Urgency: A strong, sudden need to urinate immediately.
* Nocturia: Waking up frequently during the night to urinate.
* Hesitancy: Difficulty starting the flow of urine.
* Straining: Having to strain or push to start urinating.
* Weak stream: A weak or slow urinary stream.
* Dribbling: Dribbling or leaking after urination is finished.
* Incomplete emptying: Feeling that the bladder is not fully emptied after urination.

It's important to note that these symptoms can also be caused by other conditions, such as urinary tract infections, prostate cancer, or neurological disorders, so a proper medical evaluation is necessary to determine the underlying cause and appropriate treatment.

Adrenergic alpha-antagonists, also known as alpha-blockers, are a class of medications that block the effects of adrenaline and noradrenaline at alpha-adrenergic receptors. These receptors are found in various tissues throughout the body, including the smooth muscle of blood vessels, the heart, the genitourinary system, and the eyes.

When alpha-blockers bind to these receptors, they prevent the activation of the sympathetic nervous system, which is responsible for the "fight or flight" response. This results in a relaxation of the smooth muscle, leading to vasodilation (widening of blood vessels), decreased blood pressure, and increased blood flow.

Alpha-blockers are used to treat various medical conditions, such as hypertension (high blood pressure), benign prostatic hyperplasia (enlarged prostate), pheochromocytoma (a rare tumor of the adrenal gland), and certain types of glaucoma.

Examples of alpha-blockers include doxazosin, prazosin, terazosin, and tamsulosin. Side effects of alpha-blockers may include dizziness, lightheadedness, headache, weakness, and orthostatic hypotension (a sudden drop in blood pressure upon standing).

Dihydrotestosterone (DHT) is a sex hormone and androgen that plays a critical role in the development and maintenance of male characteristics, such as facial hair, deep voice, and muscle mass. It is synthesized from testosterone through the action of the enzyme 5-alpha reductase. DHT is essential for the normal development of the male genitalia during fetal development and for the maturation of the sexual organs at puberty.

In addition to its role in sexual development, DHT also contributes to the growth of hair follicles, the health of the prostate gland, and the maintenance of bone density. However, an excess of DHT has been linked to certain medical conditions, such as benign prostatic hyperplasia (BPH) and androgenetic alopecia (male pattern baldness).

DHT exerts its effects by binding to androgen receptors in various tissues throughout the body. Once bound, DHT triggers a series of cellular responses that regulate gene expression and influence the growth and differentiation of cells. In some cases, these responses can lead to unwanted side effects, such as hair loss or prostate enlargement.

Medications that block the action of 5-alpha reductase, such as finasteride and dutasteride, are sometimes used to treat conditions associated with excess DHT production. These drugs work by reducing the amount of DHT available to bind to androgen receptors, thereby alleviating symptoms and slowing disease progression.

In summary, dihydrotestosterone is a potent sex hormone that plays a critical role in male sexual development and function. While it is essential for normal growth and development, an excess of DHT has been linked to certain medical conditions, such as BPH and androgenetic alopecia. Medications that block the action of 5-alpha reductase are sometimes used to treat these conditions by reducing the amount of DHT available to bind to androgen receptors.

Cholestenone 5 alpha-reductase is an enzyme that plays a role in the conversion of cholesterol and other steroid hormones in the body. Specifically, it catalyzes the reduction of 5,7-dihydroxycholest-4-en-3-one (also known as cholestenone) to 5α-androstan-3α,17β-diol, which is a precursor to the male sex hormone testosterone.

This enzyme is found in various tissues throughout the body, including the prostate gland, skin, and liver. In the prostate gland, 5 alpha-reductase helps regulate the growth and function of the gland by converting testosterone to dihydrotestosterone (DHT), a more potent form of the hormone.

Inhibitors of 5 alpha-reductase are sometimes used as medications to treat conditions such as benign prostatic hyperplasia (BPH) and male pattern baldness, as reducing DHT levels can help alleviate symptoms associated with these conditions.

Urology is a surgical specialty that deals with the diagnosis and treatment of diseases and conditions related to the male and female urinary tract system and the male reproductive organs. This includes the kidneys, ureters, bladder, prostate gland, and testicles. Urologists are medical doctors who have completed specialized training in this field, and they may perform various surgical procedures such as cystoscopy, lithotripsy, and radical prostatectomy to treat conditions like kidney stones, urinary tract infections, bladder cancer, enlarged prostate, and infertility.

Endometrial hyperplasia is a condition in which the lining of the uterus (endometrium) becomes thickened due to an overgrowth of cells. This occurs as a result of excessive estrogen stimulation without adequate progesterone to balance it. The thickening of the endometrium can range from mild to severe, and in some cases, it may lead to the development of abnormal or precancerous cells.

There are different types of endometrial hyperplasia, including simple hyperplasia, complex hyperplasia, and atypical hyperplasia. Simple hyperplasia has an increased number of glands but no significant architectural distortion, while complex hyperplasia shows crowded glands with architectural complexity. Atypical hyperplasia is a more serious condition characterized by the presence of abnormal cells, which can increase the risk of developing endometrial cancer if left untreated.

The primary symptoms of endometrial hyperplasia include irregular menstrual periods, heavy or prolonged bleeding, and postmenopausal bleeding. The diagnosis typically involves a transvaginal ultrasound and an endometrial biopsy to evaluate the tissue sample for cell changes. Treatment options depend on the type and severity of hyperplasia, as well as the patient's age and overall health. Hormonal therapy, progestin-based medications, or a hysterectomy (surgical removal of the uterus) may be recommended to manage this condition.

A prostatectomy is a surgical procedure where all or part of the prostate gland is removed. This surgery can be performed through various approaches such as open surgery, laparoscopic surgery, or robotic-assisted surgery. The type of prostatectomy performed depends on the reason for the surgery and the patient's individual circumstances.

There are two main types of prostatectomies: radical and simple. A radical prostatectomy is a surgical procedure to remove the entire prostate gland, seminal vesicles, and surrounding lymph nodes. This type of prostatectomy is typically performed as a treatment for prostate cancer.

A simple prostatectomy, on the other hand, involves removing only the inner part of the prostate gland that is causing symptoms such as difficulty urinating or bladder obstruction. Simple prostatectomies are usually performed to alleviate benign prostatic hyperplasia (BPH), which is a non-cancerous enlargement of the prostate gland.

Regardless of the type of prostatectomy, potential risks and complications include bleeding, infection, urinary incontinence, erectile dysfunction, and changes in sexual function. It is important for patients to discuss these risks with their healthcare provider before undergoing surgery.

Urination, also known as micturition, is the physiological process of excreting urine from the urinary bladder through the urethra. It is a complex process that involves several systems in the body, including the urinary system, nervous system, and muscular system.

In medical terms, urination is defined as the voluntary or involuntary discharge of urine from the urethra, which is the final pathway for the elimination of waste products from the body. The process is regulated by a complex interplay between the detrusor muscle of the bladder, the internal and external sphincters of the urethra, and the nervous system.

During urination, the detrusor muscle contracts, causing the bladder to empty, while the sphincters relax to allow the urine to flow through the urethra and out of the body. The nervous system plays a crucial role in coordinating these actions, with sensory receptors in the bladder sending signals to the brain when it is time to urinate.

Urination is essential for maintaining the balance of fluids and electrolytes in the body, as well as eliminating waste products such as urea, creatinine, and other metabolic byproducts. Abnormalities in urination can indicate underlying medical conditions, such as urinary tract infections, bladder dysfunction, or neurological disorders.

Laser therapy, also known as phototherapy or laser photobiomodulation, is a medical treatment that uses low-intensity lasers or light-emitting diodes (LEDs) to stimulate healing, reduce pain, and decrease inflammation. It works by promoting the increase of cellular metabolism, blood flow, and tissue regeneration through the process of photobiomodulation.

The therapy can be used on patients suffering from a variety of acute and chronic conditions, including musculoskeletal injuries, arthritis, neuropathic pain, and wound healing complications. The wavelength and intensity of the laser light are precisely controlled to ensure a safe and effective treatment.

During the procedure, the laser or LED device is placed directly on the skin over the area of injury or discomfort. The non-ionizing light penetrates the tissue without causing heat or damage, interacting with chromophores in the cells to initiate a series of photochemical reactions. This results in increased ATP production, modulation of reactive oxygen species, and activation of transcription factors that lead to improved cellular function and reduced pain.

In summary, laser therapy is a non-invasive, drug-free treatment option for various medical conditions, providing patients with an alternative or complementary approach to traditional therapies.

Urologic diseases refer to a variety of conditions that affect the urinary tract, which includes the kidneys, ureters, bladder, and urethra in both males and females, as well as the male reproductive system. These diseases can range from relatively common conditions such as urinary tract infections (UTIs) and benign prostatic hyperplasia (BPH), to more complex diseases like kidney stones, bladder cancer, and prostate cancer.

Some of the common urologic diseases include:

1. Urinary Tract Infections (UTIs): These are infections that occur in any part of the urinary system, including the kidneys, ureters, bladder, and urethra. UTIs are more common in women than men.
2. Kidney Stones: These are small, hard mineral deposits that form inside the kidneys and can cause pain, nausea, and blood in the urine when passed.
3. Benign Prostatic Hyperplasia (BPH): This is a non-cancerous enlargement of the prostate gland that can cause difficulty urinating, frequent urination, and a weak urine stream.
4. Bladder Cancer: This is a type of cancer that begins in the bladder, usually in the lining of the bladder.
5. Prostate Cancer: This is a type of cancer that occurs in the prostate gland, which is a small walnut-shaped gland in men that produces seminal fluid.
6. Erectile Dysfunction (ED): This is a condition where a man has trouble achieving or maintaining an erection.
7. Overactive Bladder (OAB): This is a condition characterized by the sudden and strong need to urinate frequently, as well as involuntary loss of urine (incontinence).

Urologic diseases can affect people of all ages and genders, although some conditions are more common in certain age groups or among men or women. Treatment for urologic diseases varies depending on the specific condition and its severity, but may include medication, surgery, or lifestyle changes.

Androstane-3,17-diol is a steroid hormone, specifically a 17-ketosteroid, that is synthesized from the metabolism of androgens such as testosterone. It exists in two forms: 5α-androstane-3α,17β-diol and 5β-androstane-3α,17β-diol, which differ based on the configuration of the A ring at the 5 position. These compounds are weak androgens themselves but serve as important intermediates in steroid hormone metabolism. They can be further metabolized to form other steroid hormones or their metabolites, such as androstanediol glucuronide, which is a major urinary metabolite of testosterone and dihydrotestosterone.

Chlormadinone Acetate is a synthetic progestin, which is a type of female sex hormone. It is used in the treatment of various medical conditions such as endometriosis, uterine fibroids, and abnormal menstrual bleeding. It works by suppressing the natural progesterone produced by the ovaries, thereby preventing the buildup of the lining of the uterus (endometrium). This medication is available in the form of tablets for oral administration.

It's important to note that Chlormadinone Acetate can cause a range of side effects and should only be used under the supervision of a healthcare provider. Additionally, it may interact with other medications, so it's important to inform your doctor about all the medications you are taking before starting this medication.

Androgen receptors (ARs) are a type of nuclear receptor protein that are expressed in various tissues throughout the body. They play a critical role in the development and maintenance of male sexual characteristics and reproductive function. ARs are activated by binding to androgens, which are steroid hormones such as testosterone and dihydrotestosterone (DHT). Once activated, ARs function as transcription factors that regulate gene expression, ultimately leading to various cellular responses.

In the context of medical definitions, androgen receptors can be defined as follows:

Androgen receptors are a type of nuclear receptor protein that bind to androgens, such as testosterone and dihydrotestosterone, and mediate their effects on gene expression in various tissues. They play critical roles in the development and maintenance of male sexual characteristics and reproductive function, and are involved in the pathogenesis of several medical conditions, including prostate cancer, benign prostatic hyperplasia, and androgen deficiency syndromes.

Testosterone is a steroid hormone that belongs to androsten class of hormones. It is primarily secreted by the Leydig cells in the testes of males and, to a lesser extent, by the ovaries and adrenal glands in females. Testosterone is the main male sex hormone and anabolic steroid. It plays a key role in the development of masculine characteristics, such as body hair and muscle mass, and contributes to bone density, fat distribution, red cell production, and sex drive. In females, testosterone contributes to sexual desire and bone health. Testosterone is synthesized from cholesterol and its production is regulated by luteinizing hormone (LH) and follicle-stimulating hormone (FSH).

Androgens are a class of hormones that are primarily responsible for the development and maintenance of male sexual characteristics and reproductive function. Testosterone is the most well-known androgen, but other androgens include dehydroepiandrosterone (DHEA), androstenedione, and dihydrotestosterone (DHT).

Androgens are produced primarily by the testes in men and the ovaries in women, although small amounts are also produced by the adrenal glands in both sexes. They play a critical role in the development of male secondary sexual characteristics during puberty, such as the growth of facial hair, deepening of the voice, and increased muscle mass.

In addition to their role in sexual development and function, androgens also have important effects on bone density, mood, and cognitive function. Abnormal levels of androgens can contribute to a variety of medical conditions, including infertility, erectile dysfunction, acne, hirsutism (excessive hair growth), and prostate cancer.

Pygeum is not a medical term itself, but it refers to the extract derived from the bark of the African plum tree (Prunus africana). Pygeum is commonly used in supplements and alternative medicines, particularly for treating symptoms associated with an enlarged prostate (benign prostatic hyperplasia or BPH). The extract contains various compounds, including phytosterols, ferulic acid, and campesterol, which are believed to have anti-inflammatory properties and may help alleviate the urinary symptoms associated with BPH. However, it is essential to consult a healthcare professional before starting any new supplement regimen, as pygeum can interact with certain medications and may have side effects.

Urologic surgical procedures in males refer to various surgical operations performed on the male urinary system and reproductive organs. These may include:

1. Transurethral Resection of the Prostate (TURP): A procedure used to treat an enlarged prostate, where excess tissue is removed through the urethra using a specialized instrument.
2. Radical Prostatectomy: The surgical removal of the entire prostate gland and some surrounding tissues, usually performed as a treatment for prostate cancer.
3. Cystectomy: Surgical removal of the bladder, often due to bladder cancer. In males, this procedure may also involve removing the prostate and seminal vesicles.
4. Nephrectomy: The surgical removal of a kidney, usually performed due to kidney disease or cancer.
5. Pyeloplasty: A procedure to correct a blockage in the renal pelvis, the part of the kidney where urine collects before flowing into the ureter.
6. Ureterostomy: A surgical procedure that creates an opening from the ureter to the outside of the body, often performed when a portion of the urinary system needs to be bypassed or drained.
7. Orchiectomy: The surgical removal of one or both testicles, often performed as a treatment for testicular cancer.
8. Vasectomy: A minor surgical procedure for male sterilization, where the vas deferens are cut and sealed to prevent sperm from reaching the semen.
9. Testicular Sperm Extraction (TESE): A surgical procedure used to extract sperm directly from the testicles, often performed as part of assisted reproductive techniques for infertile couples.

These procedures may be performed using open surgery, laparoscopy, or robotic-assisted surgery, depending on the specific circumstances and patient factors.

Congenital Adrenal Hyperplasia (CAH) is a group of inherited genetic disorders that affect the adrenal glands, which are triangular-shaped glands located on top of the kidneys. The adrenal glands are responsible for producing several essential hormones, including cortisol, aldosterone, and androgens.

CAH is caused by mutations in genes that code for enzymes involved in the synthesis of these hormones. The most common form of CAH is 21-hydroxylase deficiency, which affects approximately 90% to 95% of all cases. Other less common forms of CAH include 11-beta-hydroxylase deficiency and 3-beta-hydroxysteroid dehydrogenase deficiency.

The severity of the disorder can vary widely, depending on the degree of enzyme deficiency. In severe cases, the lack of cortisol production can lead to life-threatening salt wasting and electrolyte imbalances in newborns. The excess androgens produced due to the enzyme deficiency can also cause virilization, or masculinization, of female fetuses, leading to ambiguous genitalia at birth.

In milder forms of CAH, symptoms may not appear until later in childhood or even adulthood. These may include early puberty, rapid growth followed by premature fusion of the growth plates and short stature, acne, excessive hair growth, irregular menstrual periods, and infertility.

Treatment for CAH typically involves replacing the missing hormones with medications such as hydrocortisone, fludrocortisone, and/or sex hormones. Regular monitoring of hormone levels and careful management of medication doses is essential to prevent complications such as adrenal crisis, growth suppression, and osteoporosis.

In severe cases of CAH, early diagnosis and treatment can help prevent or minimize the risk of serious health problems and improve quality of life. Genetic counseling may also be recommended for affected individuals and their families to discuss the risks of passing on the disorder to future generations.

Androstenediols are endogenous steroid hormones that are produced in the body from dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS), which are secreted by the adrenal glands. There are two major types of androstenediols: 5-androstenediol and 4-androstenediol. These hormones can be further metabolized into testosterone and estrogens, making them important intermediates in steroid hormone synthesis.

5-androstenediol is a weak androgen that can be converted to testosterone in peripheral tissues, while 4-androstenediol has little known biological activity. Both of these compounds have been studied for their potential role in various physiological processes, including sexual differentiation, bone metabolism, and aging. However, more research is needed to fully understand their functions and clinical significance.

It's worth noting that androstenediols are also sometimes referred to as "prohormones" because they can be converted into active steroid hormones in the body. Some athletes and bodybuilders have used synthetic forms of these compounds as performance-enhancing drugs, although their use is banned by many sports organizations due to concerns about potential health risks and unfair advantages in competition.

I apologize for the confusion, but "inflation" is an economic term and not a medical one. Here's a simple explanation of what it means:

Economic inflation is a rise in the general price level of goods and services in an economy over a period of time. When the overall prices of these items increase, each unit of currency buys fewer goods and services; consequently, inflation reflects a reduction in the purchasing power of money – a loss of real value in the medium of exchange and unit of account within an economic system. This is typically measured by the Consumer Price Index (CPI) or the Producer Price Index (PPI), and central banks attempt to limit inflation, and avoid deflation, in order to keep the economy running smoothly.

Allylestrenol is a synthetic progestogen medication, which is a type of steroid hormone. It is similar in structure to the natural female sex hormone progesterone and is used in the treatment of various gynecological conditions such as menstrual disorders, endometriosis, and threatened miscarriage.

Progestogens are important for maintaining pregnancy by supporting the lining of the uterus (endometrium) and preventing muscle contractions that could lead to a miscarriage. Allylestrenol has been used as an alternative to natural progesterone because it is more potent and has a longer duration of action.

However, like other synthetic hormones, allylestrenol can cause side effects such as nausea, vomiting, headache, breast tenderness, mood changes, and irregular menstrual bleeding. It should be used with caution in women with a history of thromboembolic disease (blood clots) or liver dysfunction.

It is important to note that the use of allylestrenol and other hormonal medications should always be under the supervision of a healthcare professional, who can monitor their effectiveness and potential side effects.

Testosterone Propionate is a synthetic form of testosterone, an androgenic hormone naturally produced in the human body. The propionate ester is attached to the testosterone molecule to regulate its release into the bloodstream after injection. This results in a slower release and longer duration of action compared to unesterified testosterone.

Testosterone Propionate is primarily used in medical treatments for conditions associated with low testosterone levels, such as hypogonadism or delayed puberty in males. It helps to stimulate the development of male sexual characteristics, maintain bone density, and support red blood cell production.

It's important to note that Testosterone Propionate is available only through a prescription and its use should be under the supervision of a healthcare professional due to potential side effects and interactions with other medications or health conditions.

The urogenital system is a part of the human body that includes the urinary and genital systems. The urinary system consists of the kidneys, ureters, bladder, and urethra, which work together to produce, store, and eliminate urine. On the other hand, the genital system, also known as the reproductive system, is responsible for the production, development, and reproduction of offspring. In males, this includes the testes, epididymis, vas deferens, seminal vesicles, prostate gland, bulbourethral glands, and penis. In females, it includes the ovaries, fallopian tubes, uterus, vagina, mammary glands, and external genitalia.

The urogenital system is closely related anatomically and functionally. For example, in males, the urethra serves as a shared conduit for both urine and semen, while in females, the urethra and vagina are separate but adjacent structures. Additionally, some organs, such as the prostate gland in males and the Skene's glands in females, have functions that overlap between the urinary and genital systems.

Disorders of the urogenital system can affect both the urinary and reproductive functions, leading to a range of symptoms such as pain, discomfort, infection, and difficulty with urination or sexual activity. Proper care and maintenance of the urogenital system are essential for overall health and well-being.

Organ size refers to the volume or physical measurement of an organ in the body of an individual. It can be described in terms of length, width, and height or by using specialized techniques such as imaging studies (like CT scans or MRIs) to determine the volume. The size of an organ can vary depending on factors such as age, sex, body size, and overall health status. Changes in organ size may indicate various medical conditions, including growths, inflammation, or atrophy.

Erectile dysfunction (ED) is the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It can have physical and psychological causes, such as underlying health conditions like diabetes, heart disease, obesity, and mental health issues like stress, anxiety, and depression. ED can also be a side effect of certain medications. Treatment options include lifestyle changes, medication, counseling, and in some cases, surgery.

Castration is a surgical procedure to remove the testicles in males or ovaries in females. In males, it is also known as orchiectomy. This procedure results in the inability to produce sex hormones and gametes (sperm in men and eggs in women), and can be done for various reasons such as medical treatment for certain types of cancer, to reduce sexual urges in individuals with criminal tendencies, or as a form of birth control in animals.

"Smilax" is a genus of flowering plants, also known as greenbriars. While "Smilax" itself is not a medical term, some species of this plant have been used in traditional medicine. For instance, the roots and rhizomes of Smilax aristolochiifolia (Mexican sarsaparilla) and Smilax ornata (Jamaican sarsaparilla) have been used in traditional herbal remedies for various health conditions, including skin diseases, rheumatism, and sexual impotence. However, it's important to note that the scientific evidence supporting these uses is generally weak, and these remedies may carry risks, such as allergic reactions or contamination with harmful substances. Always consult a healthcare provider before starting any new treatment.

Acid phosphatase is a type of enzyme that is found in various tissues and organs throughout the body, including the prostate gland, red blood cells, bone, liver, spleen, and kidneys. This enzyme plays a role in several biological processes, such as bone metabolism and the breakdown of molecules like nucleotides and proteins.

Acid phosphatase is classified based on its optimum pH level for activity. Acid phosphatases have an optimal activity at acidic pH levels (below 7.0), while alkaline phosphatases have an optimal activity at basic or alkaline pH levels (above 7.0).

In clinical settings, measuring the level of acid phosphatase in the blood can be useful as a tumor marker for prostate cancer. Elevated acid phosphatase levels may indicate the presence of metastatic prostate cancer or disease progression. However, it is important to note that acid phosphatase is not specific to prostate cancer and can also be elevated in other conditions, such as bone diseases, liver disorders, and some benign conditions. Therefore, acid phosphatase should be interpreted in conjunction with other diagnostic tests and clinical findings for a more accurate diagnosis.

Thioglucosides are organic compounds that contain a sulfur atom bonded to a glucose molecule and another group, usually a methane or phenyl group. They are found in certain plants, particularly in the Brassicaceae family (which includes vegetables like broccoli, brussels sprouts, and cabbage) and in the Liliaceae family (which includes onions and garlic). These compounds are responsible for the characteristic flavors and odors of these plants. They have been studied for their potential health benefits, including anti-cancer and antimicrobial properties. However, they can also be toxic in high concentrations.

Adenocarcinoma is a type of cancer that arises from glandular epithelial cells. These cells line the inside of many internal organs, including the breasts, prostate, colon, and lungs. Adenocarcinomas can occur in any of these organs, as well as in other locations where glands are present.

The term "adenocarcinoma" is used to describe a cancer that has features of glandular tissue, such as mucus-secreting cells or cells that produce hormones. These cancers often form glandular structures within the tumor mass and may produce mucus or other substances.

Adenocarcinomas are typically slow-growing and tend to spread (metastasize) to other parts of the body through the lymphatic system or bloodstream. They can be treated with surgery, radiation therapy, chemotherapy, targeted therapy, or a combination of these treatments. The prognosis for adenocarcinoma depends on several factors, including the location and stage of the cancer, as well as the patient's overall health and age.

Nyctaginaceae is not a medical term, but a taxonomic category in botany. It refers to the family of flowering plants that includes fourty genera and around three hundred species, such as the four o'clocks (Mirabilis jalapa) and the bougainvilleas (Bougainvillea spp.).

In medical contexts, Nyctaginaceae may be mentioned in relation to the use of certain plant species from this family in traditional medicine or phytotherapy. For example, some species have been used in traditional medicine for their anti-inflammatory, analgesic, and diuretic properties. However, it is important to note that the safety and efficacy of these uses have not been thoroughly studied and are not supported by strong scientific evidence.

Immunohistochemistry (IHC) is a technique used in pathology and laboratory medicine to identify specific proteins or antigens in tissue sections. It combines the principles of immunology and histology to detect the presence and location of these target molecules within cells and tissues. This technique utilizes antibodies that are specific to the protein or antigen of interest, which are then tagged with a detection system such as a chromogen or fluorophore. The stained tissue sections can be examined under a microscope, allowing for the visualization and analysis of the distribution and expression patterns of the target molecule in the context of the tissue architecture. Immunohistochemistry is widely used in diagnostic pathology to help identify various diseases, including cancer, infectious diseases, and immune-mediated disorders.

Urethral obstruction is a medical condition that refers to a blockage in the urethra, which is the tube that carries urine from the bladder out of the body. This blockage can be partial or complete and can be caused by various factors such as scar tissue, stones, tumors, or enlarged prostate gland in men. Symptoms may include difficulty in urinating, painful urination, frequent urination, and urinary retention. If left untreated, urethral obstruction can lead to serious complications such as kidney damage or infection.

Electrosurgery is a surgical procedure that uses high-frequency electrical currents to cut, coagulate, or fulgurate tissue. It is often used in surgical procedures as an alternative to traditional scalpels and electrocautery. The electrical currents are delivered through a specialized instrument called an electrosurgical unit (ESU) that can be set to produce different forms of energy, including cutting, coagulation, or blended currents.

During the procedure, the ESU is used to apply electrical energy to the target tissue, which responds by heating up and vaporizing, allowing for precise cuts to be made. The heat generated during the procedure also helps to seal off blood vessels and nerve endings, reducing bleeding and minimizing post-operative pain.

Electrosurgery is commonly used in a variety of surgical procedures, including dermatology, gynecology, urology, orthopedics, and general surgery. It offers several advantages over traditional surgical techniques, such as reduced blood loss, shorter operating times, and faster recovery times for patients. However, it also requires specialized training and equipment to ensure safe and effective use.

Urinary catheterization is a medical procedure in which a flexible tube (catheter) is inserted into the bladder through the urethra to drain urine. This may be done to manage urinary retention, monitor urine output, or obtain a urine sample for laboratory testing. It can be performed as a clean, intermittent catheterization, or with an indwelling catheter (also known as Foley catheter) that remains in place for a longer period of time. The procedure should be performed using sterile technique to reduce the risk of urinary tract infection.

Phytotherapy is the use of extracts of natural origin, especially plants or plant parts, for therapeutic purposes. It is also known as herbal medicine and is a traditional practice in many cultures. The active compounds in these plant extracts are believed to have various medicinal properties, such as anti-inflammatory, analgesic, or sedative effects. Practitioners of phytotherapy may use the whole plant, dried parts, or concentrated extracts to prepare teas, capsules, tinctures, or ointments for therapeutic use. It is important to note that the effectiveness and safety of phytotherapy are not always supported by scientific evidence, and it should be used with caution and preferably under the guidance of a healthcare professional.

Alpha 1-Antichymotrypsin (ACT), also known as Serpin A1, is a protein found in the blood that belongs to the serine protease inhibitor family. It functions to regulate enzymes that break down other proteins in the body. ACT helps to prevent excessive and potentially harmful proteolytic activity, which can contribute to tissue damage and inflammation.

Deficiency or dysfunction of alpha 1-Antichymotrypsin has been associated with several medical conditions, including:

1. Alpha 1-Antichymotrypsin Deficiency: A rare genetic disorder characterized by low levels of ACT in the blood, which can lead to increased risk of developing lung and liver diseases.
2. Alzheimer's Disease: Increased levels of ACT have been found in the brains of individuals with Alzheimer's disease, suggesting a possible role in the pathogenesis of this neurodegenerative disorder.
3. Cancer: Elevated levels of ACT have been observed in various types of cancer, including lung, breast, and prostate cancers, potentially contributing to tumor growth and metastasis.
4. Inflammatory and immune-mediated disorders: Increased ACT levels are associated with several inflammatory conditions, such as rheumatoid arthritis, systemic lupus erythematosus (SLE), and vasculitis, suggesting its involvement in the regulation of the immune response.
5. Cardiovascular diseases: Elevated ACT levels have been linked to an increased risk of developing cardiovascular diseases, including atherosclerosis and myocardial infarction (heart attack).

Understanding the role of alpha 1-Antichymotrypsin in various physiological and pathological processes can provide valuable insights into disease mechanisms and potential therapeutic targets.

Gingival hyperplasia is a condition characterized by an abnormal growth or enlargement of the gingiva (gum tissue). This condition can be caused by various factors, including bacterial infection, certain medications (such as phenytoin, cyclosporine, and nifedipine), systemic diseases (such as leukemia, vitamin C deficiency, and Crohn's disease), and genetic disorders.

The enlarged gum tissue can be uncomfortable, irritated, and prone to bleeding, especially during brushing or flossing. It may also make it difficult to maintain good oral hygiene, which can increase the risk of dental caries and periodontal disease. Treatment for gingival hyperplasia typically involves improving oral hygiene, controlling any underlying causes, and in some cases, surgical removal of the excess tissue.

Nocturia is a common symptom characterized by the need to wake up during the night one or more times to urinate. While it's normal to urinate a few times during the night, nocturia is defined as having to urinate more than twice per night, which can disrupt sleep and lead to daytime fatigue and sleepiness.

Nocturia can be caused by various factors, including underlying medical conditions such as diabetes, bladder infections, enlarged prostate, or sleep disorders like sleep apnea. It can also be a side effect of certain medications. In some cases, nocturia may be a symptom of more serious conditions, so it's important to speak with a healthcare provider if you experience frequent nighttime urination.

Thymus hyperplasia is a condition where the thymus gland, which is a part of the immune system located in the upper chest beneath the breastbone, becomes enlarged due to an increase in the number of cells. This is different from a tumor, where there is an abnormal growth of cells that can be benign or cancerous.

Thymus hyperplasia can be classified into two types: true hyperplasia and lymphoid hyperplasia. True hyperplasia refers to an increase in the number of thymic epithelial cells, while lymphoid hyperplasia is an increase in the number of lymphocytes (a type of white blood cell) within the thymus gland.

Thymus hyperplasia can occur as a result of various factors, including autoimmune diseases, infections, and certain medications. In some cases, it may not cause any symptoms and may be discovered incidentally during imaging studies or other medical tests. However, in other cases, it may cause symptoms such as cough, chest pain, difficulty breathing, and swallowing.

Treatment for thymus hyperplasia depends on the underlying cause and severity of symptoms. In some cases, no treatment may be necessary, while in others, medications or surgery may be required.

Stromal cells, also known as stromal/stroma cells, are a type of cell found in various tissues and organs throughout the body. They are often referred to as the "connective tissue" or "supporting framework" of an organ because they play a crucial role in maintaining the structure and function of the tissue. Stromal cells include fibroblasts, adipocytes (fat cells), and various types of progenitor/stem cells. They produce and maintain the extracellular matrix, which is the non-cellular component of tissues that provides structural support and biochemical cues for other cells. Stromal cells also interact with immune cells and participate in the regulation of the immune response. In some contexts, "stromal cells" can also refer to cells found in the microenvironment of tumors, which can influence cancer growth and progression.

Diagnostic techniques in urology are methods used to identify and diagnose various urological conditions affecting the urinary tract and male reproductive system. These techniques include:

1. Urinalysis: A laboratory examination of a urine sample to detect abnormalities such as infection, kidney stones, or other underlying medical conditions.
2. Urine Culture: A test used to identify and grow bacteria from the urine to determine the type of bacterial infection present in the urinary tract.
3. Imaging Studies: Various imaging techniques such as X-rays, ultrasound, CT scans, and MRI scans are used to visualize the internal structures of the urinary tract and identify any abnormalities.
4. Cystoscopy: A procedure that involves inserting a thin tube with a camera into the bladder through the urethra to examine the bladder and urethra for signs of disease or abnormality.
5. Urodynamics: A series of tests used to evaluate bladder function, including measuring bladder pressure and urine flow rate.
6. Biopsy: The removal and examination of tissue from the urinary tract or male reproductive system to diagnose conditions such as cancer.
7. Prostate-Specific Antigen (PSA) Test: A blood test used to screen for prostate cancer by measuring the level of PSA, a protein produced by the prostate gland.
8. Voiding Diary: A record of urinary habits, including the frequency and volume of urination, that can help diagnose conditions such as overactive bladder or urinary incontinence.

Focal nodular hyperplasia (FNH) is a benign liver mass, which means it's a non-cancerous growth. It is characterized by the presence of multiple nodules or "lesions" in the liver that are well-circumscribed and have a distinctive "stars in the sky" appearance on histopathology. These lesions are composed of abnormal arrangements of liver cells, bile ducts, and blood vessels. FNH is usually discovered incidentally during imaging studies performed for unrelated reasons. It's more common in women than men, and while its cause remains unclear, it has been linked to hormonal factors. Most cases do not require treatment unless they become symptomatic or complications arise.

Orchiectomy is a surgical procedure where one or both of the testicles are removed. It is also known as castration. This procedure can be performed for various reasons, including the treatment of testicular cancer, prostate cancer, or other conditions that may affect the testicles. It can also be done to reduce levels of male hormones in the body, such as in the case of transgender women undergoing gender affirming surgery. The specific medical definition may vary slightly depending on the context and the extent of the procedure.

Androgen antagonists are a class of drugs that block the action of androgens, which are hormones that contribute to male sexual development and characteristics. They work by binding to androgen receptors in cells, preventing the natural androgens from attaching and exerting their effects. This can be useful in treating conditions that are caused or worsened by androgens, such as prostate cancer, hirsutism (excessive hair growth in women), and acne. Examples of androgen antagonists include flutamide, bicalutamide, and spironolactone.

A plant extract is a preparation containing chemical constituents that have been extracted from a plant using a solvent. The resulting extract may contain a single compound or a mixture of several compounds, depending on the extraction process and the specific plant material used. These extracts are often used in various industries including pharmaceuticals, nutraceuticals, cosmetics, and food and beverage, due to their potential therapeutic or beneficial properties. The composition of plant extracts can vary widely, and it is important to ensure their quality, safety, and efficacy before use in any application.

**Prazosin** is an antihypertensive drug, which belongs to the class of medications called alpha-blockers. It works by relaxing the muscles in the blood vessels, which helps to lower blood pressure and improve blood flow. Prazosin is primarily used to treat high blood pressure (hypertension), but it may also be used for the management of symptoms related to enlarged prostate (benign prostatic hyperplasia).

In a medical definition context:

Prazosin: A selective α1-adrenergic receptor antagonist, used in the treatment of hypertension and benign prostatic hyperplasia. It acts by blocking the action of norepinephrine on the smooth muscle of blood vessels, resulting in vasodilation and decreased peripheral vascular resistance. This leads to a reduction in blood pressure and an improvement in urinary symptoms associated with an enlarged prostate.

The urinary tract is a system in the body responsible for producing, storing, and eliminating urine. It includes two kidneys, two ureters, the bladder, and the urethra. The kidneys filter waste and excess fluids from the blood to produce urine, which then travels down the ureters into the bladder. When the bladder is full, urine is released through the urethra during urination. Any part of this system can become infected or inflamed, leading to conditions such as urinary tract infections (UTIs) or kidney stones.

The urinary bladder is a muscular, hollow organ in the pelvis that stores urine before it is released from the body. It expands as it fills with urine and contracts when emptying. The typical adult bladder can hold between 400 to 600 milliliters of urine for about 2-5 hours before the urge to urinate occurs. The wall of the bladder contains several layers, including a mucous membrane, a layer of smooth muscle (detrusor muscle), and an outer fibrous adventitia. The muscles of the bladder neck and urethra remain contracted to prevent leakage of urine during filling, and they relax during voiding to allow the urine to flow out through the urethra.

Alpha-1 adrenergic receptors (also known as α1-adrenoreceptors) are a type of G protein-coupled receptor that binds catecholamines, such as norepinephrine and epinephrine. These receptors are primarily found in the smooth muscle of various organs, including the vasculature, heart, liver, kidneys, gastrointestinal tract, and genitourinary system.

When an alpha-1 adrenergic receptor is activated by a catecholamine, it triggers a signaling cascade that leads to the activation of phospholipase C, which in turn activates protein kinase C and increases intracellular calcium levels. This ultimately results in smooth muscle contraction, increased heart rate and force of contraction, and vasoconstriction.

Alpha-1 adrenergic receptors are also found in the central nervous system, where they play a role in regulating wakefulness, attention, and anxiety. There are three subtypes of alpha-1 adrenergic receptors (α1A, α1B, and α1D), each with distinct physiological roles and pharmacological properties.

In summary, alpha-1 adrenergic receptors are a type of G protein-coupled receptor that binds catecholamines and mediates various physiological responses, including smooth muscle contraction, increased heart rate and force of contraction, vasoconstriction, and regulation of wakefulness and anxiety.

Bixaceae is a family of flowering plants that includes several genera and species, such as Bixa, Diegodendron, and Cochlospermum. These plants are native to tropical regions of the world and are known for their showy flowers and often woody or semi-woody stems. One well-known member of this family is Bixa orellana, also known as the annatto plant, which produces seeds that are used as a food coloring and flavoring agent.

Here's a medical definition of Bixaceae:

Bixaceae: A family of flowering plants in the order Malvales, characterized by having palmately lobed leaves, large showy flowers with numerous stamens, and fruit that is usually a capsule or schizocarp. Some members of this family have economic importance, such as Bixa orellana, whose seeds are used to produce annatto, a natural food coloring and flavoring agent.

Urological agents are a category of pharmaceuticals that are used to treat various conditions related to the urinary system. These medications can be used to manage symptoms or to treat underlying causes of urological disorders. The specific type of urological agent used will depend on the particular condition being treated, and may include:

* Anticholinergic agents: Used to treat overactive bladder by relaxing the muscles of the bladder.
* Alpha-blockers: Used to treat an enlarged prostate (benign prostatic hyperplasia) by relaxing the muscles around the urethra, making it easier to urinate.
* 5-alpha-reductase inhibitors: Also used to treat an enlarged prostate, these medications work by shrinking the prostate gland over time.
* Antibiotics: Used to treat urinary tract infections and other types of bacterial infections that can affect the urinary system.
* Analgesics: Used to relieve pain associated with urological conditions such as kidney stones or interstitial cystitis.
* Botulinum toxin (Botox): Injected into the bladder muscle to treat overactive bladder and reduce urinary incontinence.

It's important to note that these are just a few examples of urological agents, and there are many other medications available depending on the specific condition being treated. It is essential to consult with a healthcare provider for proper diagnosis and treatment.

The urethra is the tube that carries urine from the bladder out of the body. In males, it also serves as the conduit for semen during ejaculation. The male urethra is longer than the female urethra and is divided into sections: the prostatic, membranous, and spongy (or penile) urethra. The female urethra extends from the bladder to the external urethral orifice, which is located just above the vaginal opening.

Prostatic secretory proteins are a group of proteins that are produced and secreted by the prostate gland, which is a small gland that is part of the male reproductive system. These proteins play an important role in maintaining the health and function of the reproductive system.

One of the most well-known prostatic secretory proteins is prostate-specific antigen (PSA), which is often used as a biomarker for the early detection and monitoring of prostate cancer. PSA is a protein that is produced by the cells in the prostate gland and is normally found in low levels in the blood. However, when the prostate gland becomes enlarged or cancerous, the levels of PSA in the blood can increase, making it possible to detect these conditions through a simple blood test.

Other prostatic secretory proteins include prostate-specific acid phosphatase (PSAP), prostatein, and prolactin-inducible protein (PIP). These proteins are also produced by the prostate gland and have various functions, such as helping to liquefy semen and protecting sperm from the immune system.

It is important to note that while these proteins can provide valuable information about the health of the prostate gland, they are not foolproof indicators of disease. Other factors, such as age, inflammation, and benign prostatic hyperplasia (BPH), can also affect the levels of these proteins in the blood. Therefore, it is important to consult with a healthcare professional for proper interpretation and follow-up care.

Sulfonamides are a group of synthetic antibacterial drugs that contain the sulfonamide group (SO2NH2) in their chemical structure. They are bacteriostatic agents, meaning they inhibit bacterial growth rather than killing them outright. Sulfonamides work by preventing the bacteria from synthesizing folic acid, which is essential for their survival.

The first sulfonamide drug was introduced in the 1930s and since then, many different sulfonamides have been developed with varying chemical structures and pharmacological properties. They are used to treat a wide range of bacterial infections, including urinary tract infections, respiratory tract infections, skin and soft tissue infections, and ear infections.

Some common sulfonamide drugs include sulfisoxazole, sulfamethoxazole, and trimethoprim-sulfamethoxazole (a combination of a sulfonamide and another antibiotic called trimethoprim). While sulfonamides are generally safe and effective when used as directed, they can cause side effects such as rash, nausea, and allergic reactions. It is important to follow the prescribing physician's instructions carefully and to report any unusual symptoms or side effects promptly.

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

Thioredoxin Reductase 2 (Txnrd2) is an antioxidant enzyme that plays a crucial role in maintaining the redox balance within cells, particularly in the mitochondria. It is a member of the thioredoxin reductase family, which are selenium-containing proteins that catalyze the reduction of various substrates through the use of NADPH as an electron donor.

Txnrd2 specifically reduces the disulfide bond in mitochondrial thioredoxin 2 (Trx2), regenerating its active form and allowing it to neutralize reactive oxygen species (ROS) and maintain the redox state of proteins within the mitochondria. This enzyme is essential for protecting cells against oxidative stress, which can damage cellular components such as DNA, proteins, and lipids. Dysregulation of Txnrd2 has been implicated in various pathological conditions, including neurodegenerative diseases, cancer, and aging.

3-Oxo-5-alpha-steroid 4-dehydrogenase is an enzyme that plays a role in steroid metabolism. It is involved in the conversion of certain steroids into others by removing hydrogen atoms and adding oxygen to create double bonds in the steroid molecule. Specifically, this enzyme catalyzes the dehydrogenation of 3-oxo-5-alpha-steroids at the 4th position, which results in the formation of a 4,5-double bond.

The enzyme is found in various tissues throughout the body and is involved in the metabolism of several important steroid hormones, including cortisol, aldosterone, and androgens. It helps to regulate the levels of these hormones in the body by converting them into their active or inactive forms as needed.

Deficiencies or mutations in the 3-oxo-5-alpha-steroid 4-dehydrogenase enzyme can lead to various medical conditions, such as congenital adrenal hyperplasia, which is characterized by abnormal hormone levels and development of sexual characteristics.

Epithelium is the tissue that covers the outer surface of the body, lines the internal cavities and organs, and forms various glands. It is composed of one or more layers of tightly packed cells that have a uniform shape and size, and rest on a basement membrane. Epithelial tissues are avascular, meaning they do not contain blood vessels, and are supplied with nutrients by diffusion from the underlying connective tissue.

Epithelial cells perform a variety of functions, including protection, secretion, absorption, excretion, and sensation. They can be classified based on their shape and the number of cell layers they contain. The main types of epithelium are:

1. Squamous epithelium: composed of flat, scalelike cells that fit together like tiles on a roof. It forms the lining of blood vessels, air sacs in the lungs, and the outermost layer of the skin.
2. Cuboidal epithelium: composed of cube-shaped cells with equal height and width. It is found in glands, tubules, and ducts.
3. Columnar epithelium: composed of tall, rectangular cells that are taller than they are wide. It lines the respiratory, digestive, and reproductive tracts.
4. Pseudostratified epithelium: appears stratified or layered but is actually made up of a single layer of cells that vary in height. The nuclei of these cells appear at different levels, giving the tissue a stratified appearance. It lines the respiratory and reproductive tracts.
5. Transitional epithelium: composed of several layers of cells that can stretch and change shape to accommodate changes in volume. It is found in the urinary bladder and ureters.

Epithelial tissue provides a barrier between the internal and external environments, protecting the body from physical, chemical, and biological damage. It also plays a crucial role in maintaining homeostasis by regulating the exchange of substances between the body and its environment.

Epithelial cells are types of cells that cover the outer surfaces of the body, line the inner surfaces of organs and glands, and form the lining of blood vessels and body cavities. They provide a protective barrier against the external environment, regulate the movement of materials between the internal and external environments, and are involved in the sense of touch, temperature, and pain. Epithelial cells can be squamous (flat and thin), cuboidal (square-shaped and of equal height), or columnar (tall and narrow) in shape and are classified based on their location and function.

Phosphodiesterase 5 (PDE5) inhibitors are a class of medications that work by blocking the phosphodiesterase enzyme, specifically PDE5, which is found in the smooth muscle cells lining the blood vessels of the penis. By inhibiting this enzyme, PDE5 inhibitors increase the levels of cyclic guanosine monophosphate (cGMP), a molecule that relaxes these smooth muscles and allows for increased blood flow into the corpus cavernosum of the penis, leading to an erection.

PDE5 inhibitors are commonly used in the treatment of erectile dysfunction (ED) and include medications such as sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra), and avanafil (Stendra). These medications are usually taken orally, and their effects can last for several hours. It is important to note that PDE5 inhibitors only work in the presence of sexual stimulation, and they do not increase sexual desire or arousal on their own.

In addition to their use in ED, PDE5 inhibitors have also been shown to be effective in the treatment of pulmonary arterial hypertension (PAH) by relaxing the smooth muscle cells in the blood vessels of the lungs and reducing the workload on the heart.

Tunica intima, also known as the intima layer, is the innermost layer of a blood vessel, including arteries and veins. It is in direct contact with the flowing blood and is composed of simple squamous endothelial cells that form a continuous, non-keratinized, stratified epithelium. These cells play a crucial role in maintaining vascular homeostasis by regulating the passage of molecules and immune cells between the blood and the vessel wall, as well as contributing to the maintenance of blood fluidity and preventing coagulation.

The tunica intima is supported by a thin layer of connective tissue called the basement membrane, which provides structural stability and anchorage for the endothelial cells. Beneath the basement membrane lies a loose network of elastic fibers and collagen, known as the internal elastic lamina, that separates the tunica intima from the middle layer, or tunica media.

In summary, the tunica intima is the innermost layer of blood vessels, primarily composed of endothelial cells and a basement membrane, which regulates various functions to maintain vascular homeostasis.

Disease progression is the worsening or advancement of a medical condition over time. It refers to the natural course of a disease, including its development, the severity of symptoms and complications, and the impact on the patient's overall health and quality of life. Understanding disease progression is important for developing appropriate treatment plans, monitoring response to therapy, and predicting outcomes.

The rate of disease progression can vary widely depending on the type of medical condition, individual patient factors, and the effectiveness of treatment. Some diseases may progress rapidly over a short period of time, while others may progress more slowly over many years. In some cases, disease progression may be slowed or even halted with appropriate medical interventions, while in other cases, the progression may be inevitable and irreversible.

In clinical practice, healthcare providers closely monitor disease progression through regular assessments, imaging studies, and laboratory tests. This information is used to guide treatment decisions and adjust care plans as needed to optimize patient outcomes and improve quality of life.

Tumor markers are substances that can be found in the body and their presence can indicate the presence of certain types of cancer or other conditions. Biological tumor markers refer to those substances that are produced by cancer cells or by other cells in response to cancer or certain benign (non-cancerous) conditions. These markers can be found in various bodily fluids such as blood, urine, or tissue samples.

Examples of biological tumor markers include:

1. Proteins: Some tumor markers are proteins that are produced by cancer cells or by other cells in response to the presence of cancer. For example, prostate-specific antigen (PSA) is a protein produced by normal prostate cells and in higher amounts by prostate cancer cells.
2. Genetic material: Tumor markers can also include genetic material such as DNA, RNA, or microRNA that are shed by cancer cells into bodily fluids. For example, circulating tumor DNA (ctDNA) is genetic material from cancer cells that can be found in the bloodstream.
3. Metabolites: Tumor markers can also include metabolic products produced by cancer cells or by other cells in response to cancer. For example, lactate dehydrogenase (LDH) is an enzyme that is released into the bloodstream when cancer cells break down glucose for energy.

It's important to note that tumor markers are not specific to cancer and can be elevated in non-cancerous conditions as well. Therefore, they should not be used alone to diagnose cancer but rather as a tool in conjunction with other diagnostic tests and clinical evaluations.

Ejaculation is the discharge of semen, typically accompanied by orgasm, during sexual activity. It occurs when the male reproductive system releases semen from the penis. This process is usually brought on by sexual arousal and stimulation, which cause the sperm-carrying vas deferens to contract and push the semen into the urethra, from where it is expelled through the tip of the penis.

There are two types of ejaculation:

1. **Reflex ejaculation**: This occurs when there is a high level of sexual excitement or stimulation, leading to an involuntary and automatic response.
2. **Premature ejaculation**: This refers to the condition where ejaculation happens too quickly, often before or shortly after penetration, causing distress and affecting sexual satisfaction for both partners.

It is essential to understand that a healthy male can experience variations in the timing of ejaculation throughout their life, influenced by factors such as age, stress levels, and overall health. If you have concerns about your ejaculation patterns or any related issues, it is recommended to consult a healthcare professional for advice and treatment options.

There is no medical definition for "dog diseases" as it is too broad a term. However, dogs can suffer from various health conditions and illnesses that are specific to their species or similar to those found in humans. Some common categories of dog diseases include:

1. Infectious Diseases: These are caused by viruses, bacteria, fungi, or parasites. Examples include distemper, parvovirus, kennel cough, Lyme disease, and heartworms.
2. Hereditary/Genetic Disorders: Some dogs may inherit certain genetic disorders from their parents. Examples include hip dysplasia, elbow dysplasia, progressive retinal atrophy (PRA), and degenerative myelopathy.
3. Age-Related Diseases: As dogs age, they become more susceptible to various health issues. Common age-related diseases in dogs include arthritis, dental disease, cancer, and cognitive dysfunction syndrome (CDS).
4. Nutritional Disorders: Malnutrition or improper feeding can lead to various health problems in dogs. Examples include obesity, malnutrition, and vitamin deficiencies.
5. Environmental Diseases: These are caused by exposure to environmental factors such as toxins, allergens, or extreme temperatures. Examples include heatstroke, frostbite, and toxicities from ingesting harmful substances.
6. Neurological Disorders: Dogs can suffer from various neurological conditions that affect their nervous system. Examples include epilepsy, intervertebral disc disease (IVDD), and vestibular disease.
7. Behavioral Disorders: Some dogs may develop behavioral issues due to various factors such as anxiety, fear, or aggression. Examples include separation anxiety, noise phobias, and resource guarding.

It's important to note that regular veterinary care, proper nutrition, exercise, and preventative measures can help reduce the risk of many dog diseases.

Tissue kallikreins are a group of serine proteases that are involved in various physiological and pathophysiological processes, including blood pressure regulation, inflammation, and tissue remodeling. They are produced by various tissues throughout the body and are secreted as inactive precursors called kallikrein precursor proteins or zymogens.

Once activated, tissue kallikreins cleave several substrates, including kininogens, to generate bioactive peptides that mediate a variety of cellular responses. For example, the activation of the kinin-kallikrein system leads to the production of bradykinin, which is a potent vasodilator and inflammatory mediator.

Tissue kallikreins have been implicated in several diseases, including cancer, cardiovascular disease, and neurodegenerative disorders. They are also potential targets for therapeutic intervention, as inhibiting their activity has shown promise in preclinical studies for the treatment of various diseases.

Carbolines are a type of chemical compound that contain a carbazole or dibenzopyrrole structure. These compounds have a variety of uses, including as pharmaceuticals and dyes. Some carbolines have been studied for their potential medicinal properties, such as their ability to act as antioxidants or to inhibit the growth of certain types of cells. However, it is important to note that many carbolines are also known to be toxic and can cause harm if ingested or otherwise introduced into the body. As with any chemical compound, it is essential to use caution when handling carbolines and to follow all safety guidelines to minimize the risk of exposure.

Premature ejaculation (PE) is a common sexual disorder characterized by an uncontrolled ejaculation either before or shortly after sexual penetration, with minimal sexual stimulation and before the person wishes it. This can cause distress, frustration, and avoidance of sexual intimacy. The exact cause of PE is not fully understood, but it can be associated with psychological factors like anxiety, depression, relationship issues, as well as biological factors such as abnormal hormone levels, genetics, or nerve damage. Treatment options may include behavioral techniques, medications, and counseling.

Immunoenzyme techniques are a group of laboratory methods used in immunology and clinical chemistry that combine the specificity of antibody-antigen reactions with the sensitivity and amplification capabilities of enzyme reactions. These techniques are primarily used for the detection, quantitation, or identification of various analytes (such as proteins, hormones, drugs, viruses, or bacteria) in biological samples.

In immunoenzyme techniques, an enzyme is linked to an antibody or antigen, creating a conjugate. This conjugate then interacts with the target analyte in the sample, forming an immune complex. The presence and amount of this immune complex can be visualized or measured by detecting the enzymatic activity associated with it.

There are several types of immunoenzyme techniques, including:

1. Enzyme-linked Immunosorbent Assay (ELISA): A widely used method for detecting and quantifying various analytes in a sample. In ELISA, an enzyme is attached to either the capture antibody or the detection antibody. After the immune complex formation, a substrate is added that reacts with the enzyme, producing a colored product that can be measured spectrophotometrically.
2. Immunoblotting (Western blot): A method used for detecting specific proteins in a complex mixture, such as a protein extract from cells or tissues. In this technique, proteins are separated by gel electrophoresis and transferred to a membrane, where they are probed with an enzyme-conjugated antibody directed against the target protein.
3. Immunohistochemistry (IHC): A method used for detecting specific antigens in tissue sections or cells. In IHC, an enzyme-conjugated primary or secondary antibody is applied to the sample, and the presence of the antigen is visualized using a chromogenic substrate that produces a colored product at the site of the antigen-antibody interaction.
4. Immunofluorescence (IF): A method used for detecting specific antigens in cells or tissues by employing fluorophore-conjugated antibodies. The presence of the antigen is visualized using a fluorescence microscope.
5. Enzyme-linked immunosorbent assay (ELISA): A method used for detecting and quantifying specific antigens or antibodies in liquid samples, such as serum or culture supernatants. In ELISA, an enzyme-conjugated detection antibody is added after the immune complex formation, and a substrate is added that reacts with the enzyme to produce a colored product that can be measured spectrophotometrically.

These techniques are widely used in research and diagnostic laboratories for various applications, including protein characterization, disease diagnosis, and monitoring treatment responses.

Overactive bladder (OAB) is a urological condition characterized by the involuntary contraction of the detrusor muscle of the urinary bladder, leading to symptoms such as urgency, frequency, and nocturia (the need to wake up at night to urinate), with or without urge incontinence (the involuntary loss of urine associated with a strong desire to void). It is important to note that OAB is not necessarily related to bladder volume or age-related changes, and it can significantly impact an individual's quality of life. The exact cause of OAB is not fully understood, but it may be associated with neurological disorders, certain medications, infections, or other underlying medical conditions. Treatment options for OAB include behavioral modifications, pelvic floor exercises, bladder training, medications, and, in some cases, surgical interventions.

A biopsy is a medical procedure in which a small sample of tissue is taken from the body to be examined under a microscope for the presence of disease. This can help doctors diagnose and monitor various medical conditions, such as cancer, infections, or autoimmune disorders. The type of biopsy performed will depend on the location and nature of the suspected condition. Some common types of biopsies include:

1. Incisional biopsy: In this procedure, a surgeon removes a piece of tissue from an abnormal area using a scalpel or other surgical instrument. This type of biopsy is often used when the lesion is too large to be removed entirely during the initial biopsy.

2. Excisional biopsy: An excisional biopsy involves removing the entire abnormal area, along with a margin of healthy tissue surrounding it. This technique is typically employed for smaller lesions or when cancer is suspected.

3. Needle biopsy: A needle biopsy uses a thin, hollow needle to extract cells or fluid from the body. There are two main types of needle biopsies: fine-needle aspiration (FNA) and core needle biopsy. FNA extracts loose cells, while a core needle biopsy removes a small piece of tissue.

4. Punch biopsy: In a punch biopsy, a round, sharp tool is used to remove a small cylindrical sample of skin tissue. This type of biopsy is often used for evaluating rashes or other skin abnormalities.

5. Shave biopsy: During a shave biopsy, a thin slice of tissue is removed from the surface of the skin using a sharp razor-like instrument. This technique is typically used for superficial lesions or growths on the skin.

After the biopsy sample has been collected, it is sent to a laboratory where a pathologist will examine the tissue under a microscope and provide a diagnosis based on their findings. The results of the biopsy can help guide further treatment decisions and determine the best course of action for managing the patient's condition.

Cell proliferation is the process by which cells increase in number, typically through the process of cell division. In the context of biology and medicine, it refers to the reproduction of cells that makes up living tissue, allowing growth, maintenance, and repair. It involves several stages including the transition from a phase of quiescence (G0 phase) to an active phase (G1 phase), DNA replication in the S phase, and mitosis or M phase, where the cell divides into two daughter cells.

Abnormal or uncontrolled cell proliferation is a characteristic feature of many diseases, including cancer, where deregulated cell cycle control leads to excessive and unregulated growth of cells, forming tumors that can invade surrounding tissues and metastasize to distant sites in the body.

Ultrasonic therapy, also known as therapeutic ultrasound, is a treatment method used in physical therapy and rehabilitation that utilizes sound waves with frequencies higher than the upper limit of human hearing. In most cases, the frequency ranges from 800,000 to 2,000,000 Hz (cycles per second).

During ultrasonic therapy, a small device called a transducer is placed in direct contact with the patient's skin. The transducer emits ultrasonic waves that are primarily absorbed by soft tissues directly beneath the skin's surface, including muscles, tendons, and ligaments. These sound waves cause microscopic vibrations in the tissue molecules, which can produce various therapeutic effects:

1. Deep heating: The vibration of tissue molecules generates heat within the treated area, increasing local blood flow, reducing muscle tension, and promoting healing. This effect is particularly beneficial for treating chronic pain, muscle spasms, joint stiffness, and soft tissue injuries.
2. Cavitation: High-intensity ultrasonic waves can create tiny gas bubbles in the fluid surrounding the tissue cells. When these bubbles collapse (a process called cavitation), they generate intense localized pressure that may help break down scar tissue, reduce adhesions, and improve tissue mobility.
3. Non-thermal effects: Low-intensity ultrasonic waves can stimulate cellular processes without causing significant heating. These non-thermal effects include enhanced metabolism, increased collagen production, and improved nutrient exchange in the treated tissues, which may contribute to faster healing and tissue regeneration.

Ultrasonic therapy is generally considered safe when performed by a trained healthcare professional. However, it should be avoided in certain situations, such as over areas with malignant tumors, infected tissues, or near metal implants (due to the risk of heating). Pregnant women should also avoid therapeutic ultrasound, especially during the first trimester, due to potential risks to fetal development.

Cell division is the process by which a single eukaryotic cell (a cell with a true nucleus) divides into two identical daughter cells. This complex process involves several stages, including replication of DNA, separation of chromosomes, and division of the cytoplasm. There are two main types of cell division: mitosis and meiosis.

Mitosis is the type of cell division that results in two genetically identical daughter cells. It is a fundamental process for growth, development, and tissue repair in multicellular organisms. The stages of mitosis include prophase, prometaphase, metaphase, anaphase, and telophase, followed by cytokinesis, which divides the cytoplasm.

Meiosis, on the other hand, is a type of cell division that occurs in the gonads (ovaries and testes) during the production of gametes (sex cells). Meiosis results in four genetically unique daughter cells, each with half the number of chromosomes as the parent cell. This process is essential for sexual reproduction and genetic diversity. The stages of meiosis include meiosis I and meiosis II, which are further divided into prophase, prometaphase, metaphase, anaphase, and telophase.

In summary, cell division is the process by which a single cell divides into two daughter cells, either through mitosis or meiosis. This process is critical for growth, development, tissue repair, and sexual reproduction in multicellular organisms.

... prostatic tissue (NNT). B. Benign prostatic hyperplasia. C. High-grade prostatic intraepithelial neoplasia. D. Prostatic ... "A Systematic Review of Prostatic Artery Embolization in the Treatment of Symptomatic Benign Prostatic Hyperplasia". ... Benign prostatic hyperplasia and prostate cancer are both capable of increasing blood PSA levels and PSA elevation is unable to ... Benign prostatic hyperplasia (BPH), also called prostate enlargement, is a noncancerous increase in size of the prostate gland ...
... benign prostatic hyperplasia) including drug and non-drug BPH treatment and BPH surgery for benign prostatic hyperplasia or ... Benign Prostatic Hyperplasia (BPH) : Review in-depth clinical information, latest medical news, and guidelines on BPH ( ...
... also known as benign prostatic hypertrophy, is a histologic diagnosis characterized by proliferation of the cellular elements ... Prostatic Urethral Lift Relieves Symptoms of Benign Prostatic Hyperplasia * Fast Five Quiz: Benign Prostatic Hyperplasia Key ... encoded search term (Benign Prostatic Hyperplasia (BPH)) and Benign Prostatic Hyperplasia (BPH) What to Read Next on Medscape ... Prostatic arterial embolisation for men with benign prostatic hyperplasia: a Cochrane review. BJU Int. 2023 Jan. 131 (1):32-45 ...
Our caring team of Mayo Clinic experts can help you with your benign prostatic hyperplasia (bph)-related health concerns Start ... Benign prostatic hyperplasia: Etiology, pathophysiology, epidemiology, and natural history. In: Campbell-Walsh-Wein Urology. ... Evaluation and nonsurgical management of benign prostatic hyperplasia. In: Campbell-Walsh Urology. 12th ed. Elsevier; 2021. ... Jason Howland: Its a common problem for older men: benign prostatic hyperplasia, or BPH. ...
... intended to relieve the symptoms of obstruction and prostate tissue associated with BPH and is indicated for men with prostatic ...
Benign Prostatic hyperplasia (BPH) and Prostatitis Treatment via Dr Allens Device. Deccan Chronicle. ,. DC Correspondent ... Dr Allens Device treats benign prostatic hyperplasia (BPH) and chronic pelvic pain at home by improving blood circulation in ... The device for the first time employ body energy to treat chronic prostatic diseases effectively. Dr Allens Device ... Innovative Thermobalancing therapy and Dr Allens Device for the first time employ body energy to treat chronic prostatic ...
The Department of Urology-Research at Mayo Clinic studies new ways to treat benign prostatic hyperplasia, such as novel ... Benign Prostatic Hyperplasia. Researchers in the Department of Urology are investigating new methods to treat benign prostatic ... Areas of research in benign prostatic hyperplasia (BPH) include:. *Minimally invasive therapies; interstitial devices such as ... hyperplasia, including novel medications, surgical techniques, minimally invasive procedures and other approaches to improve ...
Similar words for Benign Prostatic Hyperplasia. Definition: noun. [ˌhaɪpɝˈpleɪˌʒiːɑː] abnormal increase in number of cells. ... Sentences with benign-prostatic-hyperplasia 1. Noun Phrase Pumpkin seed oil has been shown to help men with benign prostatic ... Researchers concluded that nettle is useful for managing the symptoms of benign prostatic hyperplasia. ...
"Is HoLEP the Only Gold Standard for Surgical Management of Benign Prostatic Hyperplasia?" written by Imran Mir, Jaydeep Date, ... A comparative study between HoLEP and bipolar TURP in the treatment of benign prostatic hyperplasia. Journal of Clinical ...
Learn more about Benign Prostatic Hyperplasia to see if you may be suffering from this condition. Call us at Summa Health ... Benign Prostatic Hyperplasia (BPH). Enlarged Prostate. Benign prostatic hyperplasia (BPH) is an enlarged prostate that often ... UroLift® (Prostatic Urethral Lift) uses special tags to compress the sides of the prostate to increase urine flow. This is a ...
The incidence of benign prostatic hyperplasia (BPH) is gradually on the increase. While conventional drugs such as the α1- ... The incidence of benign prostatic hyperplasia (BPH) is gradually on the increase. While conventional drugs such as the α1- ... In rodent models, induced prostatic inflammation was also shown to contribute to prostatic hyperplasia (Kessler et al., 1998; ... showed the levels of antioxidants in the prostatic tissue to be significantly decreased in prostatic hyperplasia (Udensi and ...
Benign prostatic hyperplasia (BPH) is an enlarged prostate gland. The prostate gland surrounds the urethra, the tube that ... Benign Prostatic Hyperplasia (BPH). Condition Basics. What is benign prostatic hyperplasia (BPH)?. Benign prostatic hyperplasia ... Simple Prostatectomy for Benign Prostatic Hyperplasia * Transurethral Incision of the Prostate (TUIP) for Benign Prostatic ... The following tips may make it easier to deal with your benign prostatic hyperplasia (BPH) symptoms. ...
If youve been diagnosed with benign prostatic hyperplasia (BPH) - noncancerous tissue growth - learn about treatment options. ... If youve been diagnosed with benign prostatic hyperplasia (BPH) - noncancerous tissue growth within the prostate - its time ... Prostatic urethral lift PUL. This procedure reshapes the prostate using a small, permanent implants to compress and lift the ... This procedure reshapes the tissue of the prostatic urethra and the bladder neck to create a wider channel through which urine ...
Expert perspective on the treatment landscape of benign prostatic hyperplasia and lower urinary tract symptoms. ... Questions spanned urologic conditions such as benign prostatic hyperplasia, overactive bladder, erectile dysfunction, kidney ... the long-term outcomes of Rezum water vapor therapy in treating men with large prostates who have benign prostatic hyperplasia ... The inclusion of iTind is reflected in a newly added statement on temporary implanted prostatic devices. ...
Interactive tool to help you figure out whether you want treatment for urinary symptoms from benign prostatic hyperplasia (BPH ... Interactive Tool: How Bad Are Your Urinary Symptoms From Benign Prostatic Hyperplasia (BPH)?. What does this tool help you ... This tool asks about your urinary symptoms from benign prostatic hyperplasia (BPH) and gives you a score based on how severe ... Lerner LB, et al (2021). Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA Guideline ...
The Role Of Stem Cells In The Treatment Of Benign Prostatic Hyperplasia. by Danny Davis , Sep 5, 2018 , Stem Cells ... Benign prostatic hyperplasia also is known as prostate gland enlargement. This disease is common in elderly people. This ...
... for benign prostatic hyperplasia (BPH) in a multicenter trial. ,i,Method,/i,. This multicenter study included 2050 patients ... "Prostatic artery embolization in the treatment of benign prostatic hyperplasia: short and medium follow-up," Techniques in ... Benign prostatic hyperplasia (BPH) is one of the most common benign urogenital lesions in most middle-aged and elderly men. Its ... S. J. Berry, D. S. Coffey, P. C. Walsh, and L. L. Ewing, "The development of human benign prostatic hyperplasia with age," The ...
In benign prostatic hyperplasia normal values for NEC and TC were determined in stages without residual urine. In contrast ... Urinary cholesterol excretion in men with benign prostatic hyperplasia and carcinoma of the prostate. In: Cancer, Vol. 43, No. ... Urinary excretion of nonesterified (NEC) and total cholesterol (TC) has been investigated in 79 patients with prostatic adenoma ... both parameters may be of value in diagnosis of prostatic cancer in even early clinical stages of the disease, especially in ...
ageing, benign prostatic hyperplasia, bladder outlet obstruction, cGMP, cinaciguat, CYB5R3, lower urinary tract symptoms, ... Benign prostatic hyperplasia (BPH) is a feature of ageing males. Up to half demonstrate bladder outlet obstruction (BOO) with ... Benign prostatic hyperplasia (BPH) is a feature of ageing males. Up to half demonstrate bladder outlet obstruction (BOO) with ... Benign prostatic hyperplasia/obstruction ameliorated using a soluble guanylate cyclase activator. *Mark ...
What Is Benign Prostatic Hyperplasia?. Benign prostatic hyperplasia (BPH), known as an enlarged prostate in layman terms, is a ... Benign prostatic hyperplasia, a condition whose histologic prevalence is approximately 10% for men in their 30s, 20% for men in ... Often, the symptoms of benign prostatic hyperplasia can mimic those of other common conditions, such as urinary tract ... Once you have been formally diagnosed with benign prostatic hyperplasia, your doctor will proceed to explain the treatment ...
... prostatic urethral lift procedure, water vapor thermal therapy, benign prostate hyperplasia (BPH), International Prostate ... minimally invasive therapies for the management of benign prostate hyperplasia (BPH), ... Pharmacotherapy vs Minimally Invasive Therapies as Initial Therapy for Moderate-to-Severe Benign Prostatic Hyperplasia: A Cost- ... In the past few years, minimally invasive therapies, such as prostatic urethral lift procedure (PUL; UroLift System, Teleflex, ...
Benign prostatic Hyperplasia) patients in terms of their efficacy and surgical outcome in our tertiary care hospital. ... Is HoLEP the Only Gold Standard for Surgical Management of Benign Prostatic Hyperplasia? Open Journal of Urology, 7, 159-165. ... 6. Gupta, N.P. and Nayyar, R. (2013) Management of Large Prostatic Adenoma: Lasers versus Bipolar Transurethral Resection of ...
A Systematic Review of Prostatic Artery Embolization in the Treatment of Symptomatic Benign Prostatic Hyperplasia Journal ... Physical Activity and Benign Prostatic Hyperplasia Journal Articles * Risk of rhabdomyolysis from 5‐α reductase inhibitors ... Cell Death Mechanisms Associated with G2Radiosensitivity in Patients with Prostate Cancer and Benign Prostatic Hyperplasia ... Photoselective vaporization for the treatment of benign prostatic hyperplasia. Journal Articles * ...
COMING SOON: In the next few weeks, Prescribers Letter is becoming Prescriber Insights, with all the high-quality content you trust, but delivered in profession-specific editions. As the updates push to your account, you will begin to see references to Prescriber Insights and a prompt to select your profession-specific edition ...
The procedure involves anatomical dissection of the prostatic tissue off the surgical capsule in a retrograde fashion using a ... high-powered holmium laser followed by intravesical morcellation of the prostatic tissue. Some groups believe that the HoLEP ...
Discover the latest trends and analysis on the Benign Prostatic Hyperplasia Treatment Market. Our report provides a ... The global Benign Prostatic Hyperplasia (BPH) Treatment market size is expected to reach USD 19.34 Billion in 2032 registering ... The global Benign Prostatic Hyperplasia (BPH) treatment market size was USD 11.50 Billion in 2022 and is expected to register a ... Benign Prostatic Hyperplasia Treatment Market, By Treatment Type (Mono Drug Therapy and Combination Drug Therapy), By Therapy ...
Durability and retreatment rates of minimal invasive treatments of benign prostatic hyperplasia: A cross-analysis of the ... has been the gold standard of the treatment of benign prostatic hyperplasia (BPH). In recent years there has been a significant ...
... have shown significant improvements in the symptoms of benign prostatic hyperplasia (BPH) without negatively affecting sexual ... study adopts a systematic approach to review the literature on treatment response in patients with benign prostatic hyperplasia ... Benign Prostatic Hyperplasia (BPH) stands as the most prevalent noncancerous growth in the prostate gland in elderly men, ... Benign prostatic hyperplasia: Review article. Latin Science. 2022.. 3. Brenes F. Diagnosis of benign prostatic hyperplasia. ...
Madersbacher S, Sampson N, Culig Z: Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini- ... Benign prostatic hyperplasia (BPH) is one of the most common non-malignant conditions in older men [1, 2]. A nationwide survey ... Roehrborn CG: Benign prostatic hyperplasia: an overview. Rev Urol 2005, 7 Suppl 9(Suppl 9):S3-s14. ... BPH, benign prostatic hyperplasia; IQR, interquartile range; SD, standard deviation; Std. Diff, standardized difference.. ...
Purchase Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia - 1st Edition. Print Book & E-Book. ISBN 9780128113974, ... Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia. From Research to Bedside. 1st. Edition. -. January 5, 2018 ... Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: From Research to Bedside offers full acknowledgment of the basic ... Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: From Research to Bedside offers full acknowledgment of the basic ...

No FAQ available that match "prostatic hyperplasia"